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PREFACE
The basis for this dissertation research stems from my academic, professional, and
personal experiences. The provision of cancer care is complex resulting in incomplete or
inconsistent implementation of interventions, policies, and guidelines into real-world
settings, thereby, reducing effectiveness. Over the years I have developed a desire to put the
patient in the center of cancer care and to think beyond the clinical encounter. In my
experience with cancer care, I recognize that patients are encountering the healthcare system
at a vulnerable time. Therefore, it is important to understand the viewpoint of the patient
while balancing the complexities of the system. However, the patient is often overlooked
when delivering patient-centered care.
My long-term goal is to become an independent researcher applying implementation
science principles to cancer prevention and control interventions, policies, and guidelines in
real-world clinical and community settings. As I continue to build a program of research, I
strive to become a leader in developing pragmatic, efficient, and effective cancer prevention
and control programs that real-world clinical and community settings can leverage to
improve cancer outcomes. Ultimately, I do not want to lose sight of the purpose of what I
want to do, which is to help and serve others.
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PURPOSE: Cancer survivors have complex journeys following the completion of active
treatment. The Institute of Medicine and other high-profile organizations have recommended
and mandated the use of a survivorship care plan (SCP) despite mixed evidence supporting
the impact of SCPs on key survivor-level outcomes. The purpose of this dissertation was to
understand the complex relationship linking the delivery of SCPs and to relevant survivorlevel outcomes.
STUDY GROUP: This dissertation focuses on breast and colorectal cancer survivors because
they comprise nearly 30% of the entire cancer survivor population in the US and are the two
most prevalent cancers in men and women.
METHODS: The first paper was a cross-sectional study using structural equation modeling
to assess hypothesized pathways linking SCPs to survivor-level outcomes among a nationally
representative sample of colorectal and breast cancer survivors from the Health Information
National Trends Survey (HINTS). The second paper involved semi-structured interviews
with safety-net breast and colorectal cancer survivors to elucidate the experiences with and

relevant outcomes of survivorship care planning. The third paper used an adapted-mixed
methods approach to provide a high-level synthesis of relevant survivor-level outcomes.
RESULTS: The first paper found no total or direct effects linking the receipt of a SCP to
survivor-level outcomes. Paper two found that the participants reported positive experiences
with the survivorship care planning process and stated that their oncology care team prepared
them for life post-treatment. The third paper modified a conceptual framework for
survivorship care planning research by emphasizing the role of communication and
distinguishing outcomes specific to the care planning process versus outcomes that likely
require a survivor-level intervention.
CONCLUSION: These findings emphasize the central role of patient-centered
communication in the survivorship care planning process and identified survivor-level
characteristics and determinants that are likely to impact outcomes across the survivorship
continuum.
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BACKGROUND
There are 15.5 million cancer survivors in the US living with the physical, cognitive,
psychosocial, and socioeconomic issues that result from cancer and its treatment, and this
number is expected to increase by 31% (20.3 million) by 2026 as the population ages and
survival rates improve.1-3 Breast and colorectal cancer survivors comprise approximately
30% of the total cancer survivor population and represent two of the most prevalent cancers
in males and females.4 Breast cancer is the most common cancer among women with an
estimated 3.5 million breast cancer survivors living in the US.4 More than 2.6 million breast
cancer survivors are older than 60 years, while 7% are younger than 50 years.4 Due to
improvements in detection and treatment, overall 5-year relative survival rates for female
patients with breast cancer continues to increase and is currently 91%.5,6 Colorectal cancer is
the fourth most common cancer diagnosis in the US, the third most common cancer among
men and women, and the second most common cause of cancer death in the US.5 An
estimated 1.5 million colorectal cancer survivors currently living in the US with 85% aged 60
years and older.4 The 5-year relative survival rates for colorectal cancer at 65% with higher
rates seen with localized disease states.
Despite improvements in survival rates, disparities exist with older age, low income, low
socioeconomic status, the presence of comorbidities, advanced stage, and poor tumor grades
being associated with lower survival or higher mortality.7,8 Studies have shown that African
American women are less likely to be diagnosed with local stage breast cancer compared to
white women and African Americans have the highest colorectal cancer mortality rates of
any racial or ethnic group.9 These racial disparities are primarily driven by socioeconomic
factors, differences in comorbidities, less access to and use of high-quality medical care, and

biological differences in cancers. 9-11 Furthermore, older cancer survivors are more likely to
have multiple chronic conditions and tend to experience decreased physical functioning
compared to younger survivors.12 Multiple chronic conditions and functional decline are
concerning given that an estimated 66.7% of all cancer survivors will be 65 years of age or
older by 2020.13 Finally, high-risk populations, such as under- or uninsured populations
served by safety-net settings, also have higher overall burden of cancer and high prevalence
of behavioral and psychosocial risk factors, making survivorship care especially important.14
Statement of the Problem
The landmark 2006 Institute of Medicine’s (IOM) report From Cancer Patient to Cancer
Survivor: Lost in Transition, identified cancer survivorship care as critical to the long-term
health of cancer survivors.2 Cancer survivors have complex journeys and are at increased risk
for poor health outcomes, cancer recurrence, and the development of comorbidities that
contribute to increased mortality rates.1,15,16 Cancer survivors must also engage in medical
follow-up care in a fragmented health care system that is ill-prepared to meet the individual
needs, preferences, and values of patients. As a result, survivors are not prepared for life after
treatment due to a lack of information about the long-term side effects of treatment, followup care and surveillance, lifestyle recommendations to stay healthy, or details related to
emotional and social support.17-21 Financial, legal, and other logistical challenges exist as
well.2,22,23
The ongoing growth in the number of survivors who are living longer after cancer
coupled with the complexities of cancer survivorship has generated increased attention from
leading health organizations to optimize survivorship care.24-26 To assist with this transition,
the IOM embraces four components of survivorship care: 1) Prevention and detection of new

cancers and recurrent cancer; 2) Surveillance for recurrence of new primary cancers; 3)
Interventions for long-term and late effects from cancer; and 4) Coordination between
specialists and primary care providers to ensure that all survivors needs are met.2

Literature Review
Survivorship Care Plans
A key recommendation from the IOM report stipulates that cancer care providers
develop and deliver to survivors’ and their primary care providers survivorship care plans
(SCPs).2 SCPs are personalized documents that include plans for follow-up care (both selfmaintenance and care received by healthcare providers), surveillance and prevention
services, supporting information about the survivors’ diagnosis, stage, and personalized
summary of treatments received. Survivors can also learn about health-promoting behaviors,
seek appropriate medical and psychological care, and learn about other relevant resources
from SCPs. SCPs are intended to facilitate communication and care coordination among
survivors, cancer care providers, and primary care providers resulting in improved health
outcomes.2 In the years following the release of the IOM report, several high-profile
organizations, including the American College of Surgeons27, the American Cancer
Society28, and others25,29,30 have recommended or mandated the use of SCPs to support the
delivery of patient-centered care by addressing the complex needs of a growing cancer
survivor population and improve health and healthcare outcomes.
Despite endorsements and mandates, SCP implementation has not been widespread
across health systems with mixed evidence supporting the effectiveness of SCPs to improve
health outcomes.31-33 Although findings from observational studies have demonstrated

positive outcomes of SCPs for survivors, including satisfaction with care 34, improved
patient-provider communication 35,36, increased confidence in one’s ability to manage care 37,
and has been linked to changes in health behaviors, 38 findings from RCTs conducted on
SCPs show no effect on survivor-level outcomes.39,40 Null findings from RCTs may be
partially explained by a lack of specificity of SCP content and studies largely focusing on
process-based proximal outcomes including survivor knowledge and satisfaction with care,
which may not be appropriate primary outcomes for measuring the impact of SCPs.32,41-43
Studies are also limited in capturing potential long-term improvements in survivor-level
outcomes, and the types of information collected to assess survivorship programs vary
greatly.32 There is a need to look beyond SCP delivery and examine proximal and distal
outcomes of SCP receipt to better understand how to evaluate and improve SCP development
and implementation.44
As outlined in Table 1, there is potential for SCPs to positively affect outcomes at the
survivor-level. Proposed outcomes of particular focus for future research include patientprovider communication, patient engagement through enhanced self-efficacy, lifestyle
behaviors, and overall health.45-47 Importantly, outcomes should be patient-centered,
capturing the most relevant health effects and other consequences.32,41,44 Being patientcentered requires an understanding of outcomes important to cancer survivors and
understanding whether survivors feel that care plans render them prepared to manage their
health and navigate their care in ways consistent with their needs and preferences.
Furthermore, it is important that outcomes evaluating SCPs consider the perspectives of
vulnerable populations that carry a disproportionate burden of cancer and its long-term
effects. Therefore, future studies should consider and describe the unique and complex

characteristics of patients that are relevant to outcomes using qualitative methods. A better
understanding of the complex relationships among SCPs and survivor-level outcomes may be
used to inform survey instruments to assess relevant of potential outcomes in diverse
populations and setting and help program strategically implement a well-defined intervention
according to a plan that addresses key survivor-level outcomes.
Table 1. Evaluating Impact of Survivorship Care Plans: Metrics for Success
•
•

Improved (perceived) patient-physician communication
Improved understanding of needed follow-up tests, their purpose and timing, and who will conduct
them
• Better understanding of potential late effects of illness and what symptoms might be important to report
• Better adherence to recommended follow-up activities; fewer requests for unnecessary tests
• Improved ability to identify providers and resources to address persistent effects of cancer and its
treatment
• Decreased cancer-related morbidity
• Improved health-related quality of life and function
• Improved healthy lifestyle choices
• Potentially improved overall survival
NOTE: Table Adapted.48

Survivor-Level Outcomes
Patient-Centered Communication
The 2013 IOM report, Delivering High Quality Cancer Care: Charting a New Course for
a System in Crisis, emphasized that care be patient-centered to meet the needs of a cancer
care delivery systems facing increased complexity and barriers to quality.49
Recommendations for SCPs explicitly state that patient-centered care should be promoted
among cancer survivors and that communication between patients and providers is central to
delivering high-quality survivorship care.50 The National Cancer Institute (NCI) monograph
Patient-Centered Communication (PCC) in Cancer Care recognized the importance of
communication in cancer care and outlines six core functions essential for meeting the
complex needs of cancer survivors: 1) Fostering healing relationships; 2) Exchanging

information; 3) Responding to emotions; 4) Managing uncertainty; 5) Making decisions; and
6) Enabling patient self-management.51
The importance of communication as a means of achieving the best health outcomes for
patients is further underscored by the IOM report, Crossing the Quality Chasm, which
identifies “patient-centeredness” as key to improving health through continuous healing
relationships.52 High-quality patient-provider communication is central to patient-centered
care and requires interactive communication where there is an active effort toward
communicating and understanding concerns and goals of care and where participation in the
process is reciprocated between patient and clinician.
Not only is PCC central to delivering high-quality cancer care, but studies have also
established a direct and indirect pathways between PCC and patient health outcomes.51,53-55
Direct pathways may result from physician’s expressing empathy that may result in fewer
negative emotions and more positive ones.56,57 In most cases, PCC affects health through
indirect or mediated routes through proximal outcomes (e.g., self-efficacy to manage health)
that could, in turn, affect health or that could contribute to the intermediate outcomes (e.g.,
adherence to lifestyle behaviors) that lead to better health.51,53
Unfortunately, the quality of PCC in cancer survivorship is suboptimal with gaps in the
communication quality most notable among survivors with multiple chronic conditions and
racial/ethnic minorities.43-45 These gaps in communication often result in confusion,
insecurity, a sense of abandonment among survivors.58,59 Poor communication between
patients and providers can have negative consequences including decreased satisfaction with
care, lower rates of cancer screening, and disparities in cancer care.55 Previous studies
reported differences in perceived patient-provider communication quality by socio-

demographics (age, race, health literacy) and other factors including depressive symptoms,
health care access, trust, and disease-related factors.17,60-63
Health Self-Efficacy
As the focus of cancer care and control efforts shifts towards more personalized and
long-term approaches, empowering cancer survivors to assume a more active role in their
own health care is becoming an increasingly essential component of cancer survivorship. 64,65
SCPs may be a tool for increasing a survivors ability to self-manage.2 Self-management in
cancer survivorship involves managing consequences of cancer and its treatment,
understanding how and when to seek support, recognizing and reporting signs and symptoms,
and adhering to lifestyle and clinical recommendations that promote survival. 66 Central to
survivors’ success in self-management is health self-efficacy or their confidence in their
ability to manage the health and healthcare consequences of cancer and its treatment. 67,68
Self-efficacy is a direct and proximal determinant of behavior change and is most
predictive of behavioral outcomes.69-71 Self-efficacy is a highly specific behavior that
influences one’s choice of activities, how long one will persevere when faced with a
challenge, and the ability to cope or handle situations that are high stress.69 Patients with
higher self-efficacy for disease management have confidence in their ability to manage
symptoms, treatment, and physical consequences of their condition, as well as their ability to
make behavioral, cognitive, and emotional changes needed to maintain quality of life and
overall health.72 Indeed, self-efficacy has been associated with emotional well-being, coping,
and adherence to lifestyle, surveillance, and follow-up behaviors in cancer survivorship.
64,66,73

It is, therefore, a common target of many self-management interventions.

Lifestyle Behaviors
There is compelling evidence linking lifestyle behaviors to health outcomes in cancer
survivors. Engaging in healthy lifestyle behaviors has been shown to mitigate cancer-related
effects, decrease the risk of comorbidities, reduce cancer recurrence, and improve 5-year
mortality rates.74 Furthermore, cancer survivors require regular follow up with their primary
care provider to adhere to age-appropriate screening, cancer screening, and other preventive
measures important for the long-term health of cancer survivors.75 A core component of
SCPs is to emphasize preventive practices and recommendations for healthly living after
cancer treatment. Yet, the focus of follow-up care is overwhelmingly on cancer surveillance,
leaving other important healthy lifestyle behaviors relatively unaddressed.21 Studies have
also shown that only 39% of cancer survivors report that a provider ever discussed lifestyle
recommendations and 32% and 12% of oncologists and primary care providers respectively
report always discussing lifestyle recommendations for survivorship care with patients.17,76,77
In order to inform and facilitate physician recommendations for cancer survivors
engagement in health behaviors, several lead health agencies, including the National
Comprehensive Care Network (NCCN), provided cancer survivor-specific health lifestyle
guidelines (Table 2).78 Survivors who follow these guidelines experience significant health
benefits and improved quality of life.
Table 2. NCCN Healthy Lifestyle Guidelines
• Engage in at least 150 minutes of moderate-vigorous physical
activity or 75 minutes of vigorous activity per week
• Engage in 2 to 3 sessions per week of strength training
• Eat a minimum of 5 servings of fruit and vegetables a day
• Avoid or stop the use of tobacco products
• Visit a primary care provider annually

Yet, the majority of cancer survivors fail to meet these lifestyle guidelines. It is estimated
that 70% of cancer survivors are overweight or obese with subsequent weight gain following
active treatment.79,80 Approximately 66% to 70% of cancer survivors do not meet the
physical activity guidelines, 20% to 50% are not meeting nutritional guidelines, 15% to 24%
continue to smoke, and approximately 23% of cancer survivors attend fewer than the
recommended number of office visits with declines seen over time.81-83 Moreover, survivors
are less likely to receive general preventive health care compared to those without a cancer
diagnosis.84 Disparities in adherence to guidelines are seen across racial/ethnic, uninsured,
and underinsured survivors.85
Summary
Cancer survivors will continue to experience significant challenges following the
completion of active treatment, such as suboptimal communication, challenges managing
cancer-related issues and overall health, adherence to lifestyle behaviors, and provision of
preventive care, critical for quality of life and overall survival. SCPs may be useful tools for
addressing these challenges; however, major questions regarding pathways linking SCPs to
appropriate survivor-level outcomes remain that impact how cancer care programs measure
the effectiveness of SCPs. To address limitations in measuring the effectiveness of SCPs,
researchers have called for studies of SCPs to identify outcomes more congruent with SCP
intervention content and targets.86
Public Health Significance
Significantly more work is needed to identify and refine the most relevant survivorlevel outcomes to be measured in studies examining SCPs, notably with more diverse
samples with characteristics that reflect the diversity found in practice. Previous studies have

examined relationships between SCPs and outcomes but most evaluated process-based
outcomes, such as knowledge and satisfaction and did not utilize a comprehensive
framework included proximal and distal survivor-level outcomes of SCPs.40,42,44 Without a
comprehensive framework, inconsistencies in results and null findings are likely to persist.
Parry et al., proposed a conceptual framework through which SCPs may impact health
outcomes, but no study has empirically tested the proposed pathways using a representative
sample of colorectal and breast cancer survivors and compared results to underserved cancer
survivors within a safety-net setting.44 In fact, few survivorship studies include under- and
uninsured patient populations who bear a disproportionate burden of cancer and have the
most challenges following the completion of active treatment. Moreover, there is a lack of
underrepresented populations included in health research overall, and may also be less
represented in outcome studies related to SCPs.
Findings from this study will address a critical gap in the literature regarding the
fundamental pathways linking SCPs to survivor-level outcomes. Furthermore, understanding
the first-hand experiences of safety-net cancer survivor populations with SCPs and
survivorship care overall is critical to the determination of the most salient survivor-level
outcomes that aligns with their needs and priorities, and may help to refine current
frameworks around SCPs. This study will build upon the existing evidence linking SCPs to
proximal and distal survivor-level outcomes that can help inform the development of a
patient-reported outcome measure that cancer care programs can use to measure the
effectiveness of SCPs on relevant outcomes that considers the diverse populations and
settings in which SCPs are delivered. Finally, findings from this study may assist cancer care

programs to strategically implement a well-defined SCP intervention according to a plan that
addresses key survivor-level outcomes.
Specific Aims or Objectives
The objective of this dissertation research is to understand the complex relationship
between receipt of a SCP with survivor-level outcomes among colorectal and breast cancer
survivors. This proposal involves primary and secondary data collection and qualitative and
quantitative methods. The overall aims of this dissertation research are as follows: (1) assess
the direct and indirect relationship between SCPs, proximal, and distal outcomes among
breast and colorectal cancer survivors using data from the Health Information National
Trends Survey (HINTS), (2) elucidate patient’s experience with and relevant outcomes of
survivorship care planning through analysis of semi-structured interviews with vulnerable
breast and colorectal cancer survivors from NCI R01CA203856- Project CONNECT at
Parkland Health and Hospital System (Parkland), and (3) characterize relevant survivor-level
outcomes at a patient and population level among breast and colorectal cancer survivors
using an adapted mixed methods approach. This dissertation includes three papers that
correspond to the three overall aims of this dissertation research:
Paper 1: Cross-sectional study assessing the hypothesized relationships between SCPs and
survivor-level outcomes among a nationally representative sample of colorectal and breast
cancer survivors.
Aim 1: Characterize the prevalence of receipt of an SCP, proximal, and distal
outcomes among colorectal and breast cancer survivors.
Aim 2: Test the measurement model for lifestyle behaviors and physical health using
confirmatory factor analysis (CFA).

Aim 3: Determine overall model fit of a conceptual framework postulating
relationships between receipt of SCP, proximal, and distal outcomes.
Aim 4: Identify direct and indirect pathways linking receipt of care plan to proximal
and distal outcomes.
Paper 2: A qualitative study elucidating the experiences with and relevant outcomes of
survivorship care planning among safety-net colorectal and breast cancer survivors.
Aim 1: Describe experience with survivorship and SCPs among safety-net colorectal
and breast cancer survivors at Parkland.
Aim 2: Characterize relevant survivor-level outcomes of survivorship care among
safety-net colorectal and breast cancer survivors at Parkland.
Aim 3: Compare and contrast relevant survivor-level outcomes by cancer site among
safety-net colorectal and breast cancer survivors at Parkland.
Paper 3: Uses an adapted mixed methods approach to synthesize relevant survivor-level
outcomes at a patient and population level among breast and colorectal cancer survivors.
Aim 1: Compare and contrast quantitative and qualitative findings from papers one
and two,
Aim 2: Refine existing survivorship care planning frameworks.
Aim 3: Suggest future directions and recommendations around the importance of
understanding survivor-level outcomes.
Conceptual Framework
Few frameworks clearly depict the proposed pathways linking SCPs to proximal and
distal survivor-level outcomes. The seminal IOM report From Cancer Patient to Cancer
Survivor: Lost in Transition, provided a clinical framework of SCPs and outlined four

essential components of cancer survivorship that may affect survivor-level outcomes, such as
patient-centered communication (PCC).2 Parry et al. proposed a clinical framework based off
the landmark IOM report in which SCPs facilitate patient-provider communication, in turn,
resulting in improvements in survivor-level outcomes, such as management of late effects,
and long term physiological and psychosocial outcomes.44 However, the framework does not
define indirect effects of SCPs on survivor-level outcomes. Recommendations for SCPs also
explicitly state that communication between patients and providers, or patient-centered
communication (PCC), is central to delivering high-quality survivorship care.50 PCC is
suggested to be an important proximal outcome of SCPs that may impact long-term health
directly or indirectly via proximal (health self-efficacy) and intermediate outcomes
(adherence to lifestyle behaviors).51,63 Lafata et al. proposed a conceptual framework in
which the communication exchange between the patient and the provider itself can directly
lead to improved health outcomes during and after cancer. Yet, in most cases,
communication likely affects health outcomes indirectly through affective-cognitive
outcomes, such as health self-efficacy, and behavioral outcomes, such as exercise and
nutrition.63,86
The conceptual framework guiding this dissertation adapts Parry et al. model of
Survivorship Care Planning Research with Lafata et al. model of Patient-Clinician
Communication and clearing depicts the direct and indirect pathways through which SCPs
may impact proximal and distal health outcomes (Figure 1).

Figure 1. Conceptual Framework depicting hypothesized pathways linking SCPs to survivor-level outcomes.

METHODS PAPER 1
Paper 1 assesses the hypothesized relationships between SCPs and survivor-level
outcomes among a nationally representative sample of colorectal and breast cancer survivors
from the Health Information National Trends Survey (HINTS). Informed by the conceptual
framework, SEM techniques will be used to examine overall model fit of conceptual
relationships and identify direct and indirect pathways linking receipt of treatment
summaries, a proxy for SCPs, to proximal and distal survivor-level outcomes.
Data Source and Sample
The HINTS is a nationally representative probability survey funded by the NCI
designed to assess current access to and use of information about cancer across the cancer
care continuum from cancer prevention, early detection, diagnosis, treatment, and
survivorship.87 We combined data from two iterations of HINTS: HINTS 4, Cycle 4 (fielded
August-November, 2014, response rate 34.4%), and HINTS 5, Cycle 1 (fielded January-May,
2017, response rate 32.4%). These iterations were selected due to their proximity to the
Commission on Cancer (CoC) 2015 mandate for SCP delivery and are the only two surveys
that include all outcomes of interest following the release of the IOM report. Information on
the two-stage stratified sampling design and other methodological details are described on
the HINTS website (https://hints.cancer.gov/data/survey-instruments.aspx). For the analysis,
we restricted the sample to those who reported a personal history of colorectal or breast
cancer. We excluded those who never received treatment for their cancer or were still in
active treatment since these individuals would not be expected to have received an SCP.

Survey Items
Appendix A provides a list of relevant HINTS survey items, responses for each item
of interest, and analytic categories. The primary predictor variable in the model is the receipt
of an SCP. Survey items representing PCC, health self-efficacy, and a latent measure of
adherence to health behaviors will serve as both predictor and outcome variables in the
model. The primary outcome variable is a latent measure of self-reported physical health.
Receipt of an SCP: Respondents answered the following questions: “Did you ever receive
a summary document from your doctor or other health care professional that listed all of
the treatment you received for your cancer?” Response options were yes or no. This item
has previously been used as a proxy for SCPs and treatment summaries.88
Patient-Centered Communication: Respondents were asked six questions corresponding to
the six functions of PCC and overlapping concepts. However, the item representing
fostering healing relationships was not included in the HINTS 5, Cycle 1 iteration. To
address this limitation, the six items consistent across all iteration were reviewed and a
Cronbach’s alpha was obtained comparing the initial set of six HINTS PCC items used in
previous studies to the revised set PCC items proposed for this analysis using the HINTS
4, Cycle 4 sample. Results indicated strong reliability of the new items (a = 0.93) similar
to the initial set of items (a = 0.92). Therefore, the following items will be included in the
analysis: How often did the doctors, nurses, or other health care professional you saw
during the past 12 months do each of the following: (1) Give you a chance to ask all the
health related questions you had? (reflecting Fostering Healing Relationships) (2) Give
the attention you needed to your feelings and emotions? (Responding to emotions) (3)
Involve you in decisions about your health care as much as you wanted? (Making

decisions) (4) Make sure you understood the things you needed to do to take care of your
health? (Enabling self-management) (5) Explain things in a way you could understand?
(Exchanging Information) (6) Help you deal with feelings of uncertainty about your health
or healthcare? (Managing uncertainty). Response options were always, usually,
sometimes or never. Following previous approaches, items were reversed scored prior to
analysis and an overall PCC score was created, where higher scores indicate higher levels
of PCC.89-91
Health Self-Efficacy: Respondents were asked to rate their confidence in their ability to
take care of their health. Response options were completely confident, very confident,
somewhat confident, a little confident, and not confident at all. Consistent with previous
item use, items were reversed score prior to analysis and summed to create a continuous
overall score for health self-efficacy with higher scores indicating greater levels of selfefficacy to manage health.92
Health Behaviors: Evidence supports combining health behaviors that are health
enhancing into a latent variable since there is a tendency for these behaviors to cooccur.93,94 Respondents provided information on healthy lifestyle behaviors including
aerobic physical activity, fruit and vegetable intake, and tobacco use. Responses were
categorized to align with NCCN recommended guidelines (see Appendix A) and loaded
onto a single categorical latent variable.95
Physical Health: Evidence supports the creation of a latent measure for physical health by
combining BMI, number of comorbidities, and subjective self-ratings of health.96 BMI
was derived using self-report height and weight. Respondents were asked to indicate
yes/no to ever being told if they had each of the following conditions: diabetes or high

blood sugar, hypertension or high blood pressure, a heart condition, chronic lung disease,
or arthritis or rheumatism. To calculate the number of chronic conditions, responses were
summed with higher scores indicating a higher number of chronic conditions. Finally,
respondents were also asked to rate their overall health with response options being
excellent, very good, good, fair, and poor. Responses were reversed scored with high
scores indicating better overall health.
Statistical Analysis
Prior to the analysis, we performed all necessary data management and screening
procedures including merging of data sets, creation of new variables, assessment of
normality, linearity, missing data, and outliers using SAS 9.4 (SAS Institute Inc., Cary, NC,
USA). To reduce the risk of a Type 1 error, we incorporated HINTS-supplied survey weights
using jackknife variance estimation techniques into inferential analyses to account for the
complex HINTS sampling design and to calculate nationally representative estimates. 97 All
analyses were performed again removing replicate weights but maintaining survey weights as
there is debate concerning the added utility that replicate weights bring to the following
analysis.
Despite efforts to improve the completeness of data collection, missing data in the
HINTS dataset is not uncommon and can result in a reduction in sample size and possible
bias. Prior to analysis, we assessed the percentage of missing data and the pattern of missing
data. There are two techniques for addressing missing data for this analysis; maximum
likelihood (ML) and multiple imputation. ML is the default in most structural equation
modeling software’s and uses all observable data to estimate the missing portions of a
variable. However, ML is unpractical unless the data contain only a few distinct patterns of

missing data and assumes multivariate normality. If the fraction of missing data is greater
than 10 percent, multiple imputation techniques prior to analysis will be performed. Multiple
imputation replaces each missing item in the dataset with an imputed value, and then
analyzes the dataset as if it were complete. The advantage of multiple imputation is that it
increases the efficiency in estimation and the ability to incorporate information in an effort to
reduce nonresponse bias.98
This analysis includes descriptive statistics of the sample including demographic,
clinical, and cancer-related information, gender, age, education, race, income, health
insurance, and cancer site. We used structural equation modeling (SEM) using MPlus Editor
7 (Los Angeles, CA: Muthén & Muthén) to test the direct and indirect effects between SCPs,
proximal, and distal outcomes. SEM is a multivariate statistical analysis technique that
combines factor analysis and multiple regression analysis to analyze the structural
relationships between measured variables and latent constructs. There are two types of
models specified in SEM – the measurement model and the structural model. The
measurement model represents how measured variables come together, or the creation of
latent variables, while the structural model represents how constructs are related to other
construct and tests the proposed relationships between variables.
We calculated descriptive statistics including means/frequencies and percent/standard
deviations of relevant outcomes identified in our conceptual framework and used
Confirmatory Factor Analysis (CFA) to validate the measurement portion of the model
(latent structure of health behaviors and physical health) using a robust estimator based on
the normality of the data. Empirical evidence supports the creation of a one-factor reflective

model for both health behaviors and physical health. To identify each latent model, we fixed
the first item loading onto the latent factor to one.
We assessed overall model fit using chi-square goodness-of-fit test, , comparative fit
index (CFI), the root mean square error of approximation (RMSEA), and weighted root mean
square residual (WRMR).99-101 Examination of RMSEA values below 0.10, CFI values above
0.95, and WRMR values below 1.0 suggest approximate model fit. We examined
modification indices, standardized factor loadings, and residuals to assess localized areas of
ill fit. Based on fit diagnostic information and substantive justification, the model may be
revised to fit the data to improve the goodness of fit. An indicator being specified to load
onto a latent factor based on previous research may have no salient relationship to the factor.
In this instance, the indicator may be dropped from the model and examined as a manifest
variable. We also examined the correlations between indicators to detect problematic
discriminant validity using guidelines for multicolinearity in regression (correlation ≥ 0.85).
If indicators overlap to this degree, factors may be combined or dropped to acquire a more
parsimonious solution if supported by a clear rationale. In the event that neither latent
structure shows a good fit to the data, a subset of indicators will be retained based off
localized fit indices, discriminant validity, and justification within the literature.
Following the CFA, we tested the hypothesized structural model of both latent and
observed variables using a robust estimator. The model included both continuous and
categorical variables. All variables were assessed for normality based on skewness and
kurtosis. Figure 2 presents the a priori set of hypothesized direct and indirect relationships
between variables and the final structural model. The latent variables are depicted as ovals
and observed variables are in rectangles. The adequacy of the structural model will be tested

using the chi-square goodness-of-fit test, CFI, RMSEA, and WRMR. We obtained
standardized parameter estimates representing direct and indirect effects with the significance
level set to 0.05.
Figure 2. Hypothesized pathways linking SCPs to Proximal and Distal Outcomes

METHODS PAPER 2
Paper 2 elucidates safety-net breast and colorectal cancer survivors’ experience with
and relevant outcomes of survivorship care planning through the analysis of semi-structured
interviews and builds upon the parent study NCI R01CA203856- Project CONNECT at
Parkland Health and Hospital System (Parkland). Project CONNECT is a quasi-experimental
hybrid implementation-effectiveness study aimed at adapting, implementing, and evaluating
three evidence-based care coordination strategies among vulnerable breast and colorectal
cancer survivors with multiple comorbidities receiving care at Parkland.
Aim 1: Describe experience with survivorship and SCPs among safety-net colorectal
and breast cancer survivors at Parkland.
Aim 2: Characterize relevant survivor-level outcomes of survivorship care among
safety-net colorectal and breast cancer survivors at Parkland.
Aim 3: Compare and contrast relevant survivor-level outcomes by cancer site among
safety-net colorectal and breast cancer survivors at Parkland.
Setting
This study captured under- and uninsured populations at Parkland – the sole
integrated safety-net provider for approximately one million under- and un-insured Dallas
County residents living at < 200% poverty level in Texas. Safety-net providers serve patients
regardless of their ability to pay, whose patient mix includes substantial numbers of
uninsured, Medicaid, and other disparate populations.102 Breast and colorectal are two of the
most prevalent cancers treated at Parkland with approximately 250 new cases diagnosed each
year. The Parkland cancer program is accredited by the American College of Surgeons
Commission on Cancer, thus mandated to provide all survivors with an SCP, making them an

ideal population for understanding experiences with survivorship care planning. Preliminary
data from Project CONNECT suggests that SCP delivery is limited and providers’ experience
challenges communicating details of survivorship care to patients, particularly among lowincome, racial/ethnic minority survivors struggling with multiple chronic conditions.
Patient Sample and Recruitment
Using electronic health record data and registry data, we identified patients diagnosed
with stage I, II, and III breast or colorectal cancer who completed active treatment in the last
18 months and were enrolled in Project CONNECT. We defined the completion of active
treatment as the completion of initial surgical treatment and/or initial adjuvant chemotherapy
and radiation. Those with in situ (stage 0) and metastatic disease (stage IV) were excluded
because they are unlikely to receive a SCP. Those with impaired hearing or speech and/or the
inability to comprehend or speak English, were also excluded from participation.
A non-proportional quota sample was chosen from eligible participants who
expressed an interest in taking part in an interview with the research team. The research staff
aimed to recruit a diverse sample of survivors to examine potential differences in posttreatment experiences and outcomes by cancer site (50% Breast, 50% Colorectal).
Participants were selected to populate the cancer site subgroup with the aim of recruiting a
maximum of 10 participants who completed treatment in the last 18 months. Up to 6 attempts
(day, evening, weekend) were made to reach eligible participants. All interviews acquired
informed consent and were performed using a semi-structured interview guide by a trained
member of the research staff. Interviews were audio-recorded and participants were
compensated $20 for their time.

Patient Telephone interviews
Prior experience with Parkland cancer patients shows that patient are able and willing
to complete phone interviews. Each telephone interview lasted approximately 30-45 minutes.
The semi-structure interview guide was informed by the conceptual framework and focused
on the participants experience with survivorship care planning and their experience following
the care planning visit. We asked participants to reflect on their last treatment visit with their
oncology care team to understand their experiences with survivorship care planning.
Specifically, we asked the participants to recall the information they received and discussed
with their oncology care team during their last treatment visit. To elucidate potential
outcomes of survivorship care more broadly, we asked participants to describe their posttreatment experience. We probed participants to discuss how they knew they were doing well
post-treatment and to identify the most important thing they could do to stay healthy after
cancer treatment. See Appendix B for the final interview guide.
Data Collection and Analysis
All data was professionally transcribed, de-identified, and analyzed in NVivo (QSR,
International, AUS). Two members of the research team performed thematic content analysis
using a deductive-inductive approach.103 Each transcript was reviewed in its entirety without
coding to allow themes and subthemes to emerge. Then, drawing on constructs from our
conceptual model, we developed a deductive code structure that was applied to a random
selection of transcript during an initial open coding session.104,105 As new ideas emerged, the
research team considered inductive themes and domains, allowing the codebook to
evolve.104,105 The revised codebook was then applied to the remaining transcripts. The team
coded the transcripts independently before coming together to compare codes. All

discrepancies in codes were resolved through consensus and analysis continued until no new
ideas emerge from subsequent interviews and resulting themes were deemed saturated.106

METHODS PAPER 3
Paper 3 integrates findings from papers one and two to provide a high level synthesis
of relevant survivor-level outcomes among breast and colorectal cancer survivors using an
adapted mixed methods approach.
Aim 1: Compare and contrast findings from paper two with results from a subset of
breast and colorectal cancer survivors from paper one.
Aim 2: Refine conceptual framework informed by existing frameworks of SCPs.
Aim 3: Suggest future directions and recommendations around the importance of
understanding survivor-level outcomes.
Data Collection and Analysis
The quantitative and qualitative data from papers one and two were analyzed
separately and integrated for final analysis (see Appendix C). Due to differences in the
sample composition between the two data sources, we pulled an additional subset of
colorectal and breast cancer survivors from the initial quantitative HINTS dataset to be more
similar to the qualitative interview sample. The new subset of breast and colorectal cancer
survivors was limited to non-Hispanic (NH) white and black women only with at least two
chronic conditions who completed treatment in the last five years. We calculated descriptive
statistics including weighted means/frequencies and percent/standard deviations of the
HINTS survey items representing the outcomes identified in our conceptual framework (i.e.,
receipt of an SCP, health self-efficacy, PCC, health behaviors, and physical health) across
both samples. All analyses incorporated the HINTS supplied survey weights to calculate
nationally representative estimates.

Interpretation and reporting of data followed a narrative approach.107,108 Results were
triangulated and connected to each other thematically, and the qualitative and quantitative
data weave back and forth around similar themes or concepts (see Appendix C).108 The
narrative approach provides intragroup comparisons of the results from the quantitative data
that are either supported or challenged by text from the qualitative database.109 For example,
if the proportion of survivors receiving a care plan was low at a population level, the
qualitative results may assist in identifying barriers at Parkland that can serve as a point of
intervention (hypothesis-generating). Themes focused on outcomes informed by the
conceptual framework. Finally, the analytic team reviewed all data with special attention to
narrowing the broader conceptual framework driving this study to include only the specific
components confirmed following integration and their possible causal linkages of interest.110
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Introduction
Following the completion of active cancer treatment, cancer survivors remain at
increased risk for poor health outcomes, cancer recurrence, and the development of chronic
conditions that contribute to increased mortality rates.1-3 In the years following the release of
the landmark Institute of Medicine (IOM) report From Cancer Patient to Cancer Survivor:
Lost in Transition, several high-profile organizations, including the American College of
Surgeons4, the American Cancer Society5, and others6-8 have recommended or mandated the
use of survivorship care plans (SCPs) to address the complex needs of a growing cancer
survivor population. SCPs are tailored documents that combine personalized treatment
summaries with plans for follow-up care, surveillance, preventions, and supporting
information around health-promoting behaviors.9 SCPs are intended to facilitate
communication among survivors and clinical care teams, resulting in improved health
outcomes.9,10
Evidence regarding the effectiveness of SCPs on health and healthcare outcomes
remains mixed due to inconsistencies across studies in the selection of outcomes for
measuring SCP effectiveness.11-13 As a result, researchers have advocated for studies that
identify the most appropriate outcomes of SCP receipt, particularly at the survivor-level.
Findings from observational studies show that SCPs have the ability to impact both proximal

and distal survivor-level outcomes including patient-provider communication,14,15 increased
confidence in one’s ability to manage care,16 changes in health behaviors, and improvements
in overall health.17 However, a recent systematic review found that many randomized
controlled trials of SCP delivery on patient-reported health status and perceptions of care
yielded statistically non-significant findings.13 Among the few studies with significant
findings, results suggest that SCPs are more likely to impact proximal outcomes including
knowledge and satisfaction with care.12,18-22
Without a comprehensive framework for studying survivorship care planning,
inconsistencies in measured outcomes are likely to persist, limiting the extent to which
definitive conclusions can be drawn about the impact of SCPs. Yet, few frameworks of
survivorship care planning exist that depict the proposed pathways linking SCPs to survivorlevel outcomes. Parry et al. proposed a clinical framework of Survivorship Care Planning in
which SCPs facilitate communication that, in turn, influence later outcomes, such as
management of late effects, and long term physiological and psychosocial outcomes.23
However, the framework does not depict indirect pathways linking the delivery of SCPs to
survivor-level outcomes. Recommendations for SCPs also explicitly state that
communication between patients and providers, or patient-centered communication (PCC), is
central to delivering high-quality survivorship care.24 Lafata et al. proposed a conceptual
framework in which the communication exchange between the patient and the provider itself
can directly lead to improved health outcomes during and after cancer. Yet, in most cases,
communication likely affects health outcomes indirectly through affective-cognitive
outcomes, such as health self-efficacy, and behavioral outcomes, such as exercise and
nutrition.25,26

To date, few studies have utilized a comprehensive framework of survivorship care
planning and the majority of studies that have identified direct pathways linking SCPs to
various outcomes primarily control for sociodemographic, clinical, and cancer-related
characteristics and have tested these pathways in a single cancer site. As a result, no study
has simultaneously tested the direct and indirect pathways linking SCPs to survivor-level
outcomes.23,27 Examining these proposed pathways simultaneously using structural equation
modeling (SEM) in a representative sample of cancer survivors would address this gap by
offering a more complete and comprehensive approach to understanding the impact of
receiving a SCP on survivor-level outcomes.
Therefore, the objective of this study is to assess the direct and indirect relationships
between the receipt of an SCP on proximal and distal survivor-level outcomes among a
nationally representative sample of cancer survivors using data from the Health Information
National Trends Survey (HINTS). Based on existing frameworks of survivorship care
planning research and communication, this study attempts to identify outcomes of
survivorship care planning at the survivor-level and test a hypothesized model postulating
proposed pathways through which SCPs effect proximal and distal outcomes. We used an
SEM approach to (1) test a measurement model for lifestyle behaviors and physical health
using confirmatory factor analysis (CFA); (2) assess direct and indirect pathways linking
receipt of SCP to proximal and distal outcomes; and (3) determine overall model fit of a
conceptual framework postulating relationships between receipt of a SCP, proximal, and
distal outcomes. To our knowledge, no study has examined the direct and indirect pathways
linking SCPs to proximal and distal outcomes. Findings from this study will fill an important

gap in existing research on the most appropriate survivor-level outcomes for measuring SCP
effectiveness and may help inform future models of survivorship care planning.
Methods
Survey Design and Sample
The Health Information National Trends Survey (HINTS) is a nationally
representative cross-sectional probability survey administered in English and Spanish by the
National Cancer Institute. Respondents complete a one-time survey to assess current access
to and use of information about cancer across the cancer care continuum from cancer
prevention, early detection, diagnosis, treatment, and survivorship. Information on the twostage stratified sampling design and other methodological details are described on the HINTS
website (https://hints.cancer.gov/data/survey-instruments.aspx).
We combined data from two iterations of HINTS: HINTS 4, Cycle 4 (fielded AugustNovember, 2014, response rate 34.4%), and HINTS 5, Cycle 1 (fielded January-May, 2017,
response rate 32.4%). These iterations were selected due to their proximity to the
Commission on Cancer 2015 mandate for SCP delivery and are the only two surveys that
include all outcomes of interest following the release of the IOM report. For this analysis, we
restricted the sample to those who reported a personal history of breast or colorectal cancer
and excluded those who indicated that they were still in active treatment – defined as still
receiving chemotherapy, radiation, and/or surgery for their cancer - to align with the posttreatment phase of cancer survivorship.9 We chose breast and colorectal cancer survivors
because they comprise approximately 30% of the total cancer survivor population and
represent two of the most prevalent cancers in males and females.28 The final sample size for
the analysis was 212 cancer survivors.

Survey Items
Respondents reported sociodemographic, clinical, and cancer-related information,
including gender, age, education, race, income, health insurance status, and cancer site.
Appendix A provides a list of relevant HINTS survey items, responses for each item of
interest, and analytic categories used in this analysis.
Receipt of SCP. The primary predictor variable in the model was receipt of an SCP.
Respondents answered the following questions: “Did you ever receive a summary
document from your doctor or other health care professional that listed all of the
treatment you received for your cancer?” Response options were yes or no. This item
has previously been used as a proxy for SCPs.29
Patient-Centered Communication. Survivors were asked about their communication
experiences during the prior 12 months with doctors, nurses, or other health
professionals. These items were grounded in the PCC framework originally proposed
by Epstein and Street, corresponding to the six core functions of PCC and
overlapping concepts that impact the communication exchange.30 Response options
were always, usually, sometimes or never. Items were reverse scored prior to analysis
and summed to create a continuous overall score for PCC, where higher scores
indicate higher levels of PCC. 31,32
Health Self-Efficacy. Respondents were asked to rate their confidence in their ability
to take care of their health. Response options were completely confident, very
confident, somewhat confident, a little confident, and not confident at all. Items were
reverse scored and treated as a continuous variable with higher scores indicating
higher levels of self-efficacy to manage health.33

Health Behaviors. Respondents provided information on healthy lifestyle behaviors,
including aerobic physical activity, fruit and vegetable intake, and tobacco use.
Evidence supports combining health behaviors that are health-enhancing into a latent
variable since there is a tendency for these behaviors to co-occur.34,35 Responses were
categorized to align with the National Comprehensive Care Networks (NCCN)
recommended guidelines and loaded onto a single latent variable.36
Physical Health. Respondents provided information around their physical health,
including their perceived health status, body mass index (BMI), and number of
comorbidities. The HINTS survey includes a variable calculating BMI for all
respondents who self-reported height and weight. To calculate the number of chronic
conditions, respondents indicated yes/no to ever being told if they had each of the
following conditions: diabetes or high blood sugar, hypertension or high blood
pressure, a heart condition, chronic lung disease, or arthritis or rheumatism.
Responses were summed with higher scores indicating a higher number of chronic
conditions. Finally, respondents were also asked to rate their perceived overall health
with response options being excellent, very good, good, fair, and poor. Responses
were reverse scored with high scores indicating better overall health.
Data Analysis
We calculated descriptive statistics of the sample, including sociodemographic,
clinical, and cancer-related information, including gender, age, education, race, income,
health insurance, and cancer site. We also characterized the prevalence of receiving an SCP
and provide descriptive statistics for survey items corresponding to the proximal and distal
outcomes identified in our conceptual framework.

We used SEM to test whether our conceptual model was supported by the HINTS
data. SEM is a multivariate statistical analysis technique that combines factor analysis and
multiple regression analysis to analyze the structural relationships between measured
variables and latent constructs. There are two types of models specified in SEM – the
measurement model and the structural model. The measurement model represents how
measured variables come together, or the creation of latent variables, while the structural
model represents how constructs are related to other construct and tests the proposed
relationships between variables. We developed and tested two latent variables for healthy
lifestyle behaviors and physical health using confirmatory factor analysis (CFA) as described
by Brown.37 To accommodate the use of some categorical indicators and account for missing
data, we estimated parameters using weighted least squares with robust standard errors
(WLSMV). Parameters were therefore estimated in terms of linear regression coefficients for
continuous indicators and by probit regression coefficients for categorical indicators (Muther
& Muther).
After evaluating the fit and factor loadings of the measurement model, we specified
an a priori structural model as proposed in Figure 1. The hypothesized structural model is
based on Parry et al. clinical framework of Survivorship Care Planning in which SCPs
facilitate communication, in turn, resulting in improved health outcomes.23 We adapted Parry
et al. framework to emphasize PCC by incorporating Lafata et al. conceptual framework in
which the communication exchange between the patient and the provider itself can directly
lead to improved health outcomes during and after cancer and, in most cases, affects health
indirectly through health self-efficacy and healthy behaviors.25,26

For the full structural model we obtained standardized parameter estimates
representing direct and indirect effects with the significance level set to 0.05 using the
WLSMV estimator. Overall model fit was assessed using chi-square, comparative fit index
(CFI), the root mean square error of approximation (RMSEA), and weighted root mean
square residual (WRMR).38-40 Examination of RMSEA values below 0.10, CFI values above
0.95, and WRMR values below 1.0 suggest approximate model fit. Modification indices,
standardized factor loadings, and residuals were used to assess localized areas of ill fit.
Missing data were handled by pairwise deletion, which treats missingness as a function of the
observed covariates but not of the observed outcomes.41,42
We used the MPlus Editor 7 (Los Angeles, CA: Muthén & Muthén) for all modeling
and SAS 9.4 (SAS Institute Inc., Cary, NC, USA) for all data cleaning, recodes, and
descriptive analysis. To reduce the risk of a Type 1 error, HINTS-supplied survey weights
using jackknife variance estimation techniques were incorporated into analyses to account for
the complex HINTS sampling design and to calculate nationally representative estimates. 44
We did this by using the TYPE = COMPLEX option in the ANALYSIS command of Mplus
and specified the weight and replicate weight variables in the data.
Results
Table 1 displays the sociodemographic, clinical, and cancer-related characteristics of
the sample and is representative of the US population of breast and colorectal cancer
survivors. The majority of the sample was non-Hispanic (NH) white, breast cancer
survivors, over the age of 50, with a high school degree or higher. Nearly the entire sample
reported having health insurance, and more than half had an income less than $50,000.

Table 2 characterizes the prevalence of survivors receiving an SCP and proximal and
distal outcomes of SCP delivery identified in our conceptual framework. Almost a third of
respondents indicated that they did not receive an SCP from their provider but, on average,
report high levels of PCC and feel confident in their ability to manage their health. Nearly
72.3% of breast and colorectal cancer survivors are not meeting the recommended NCCN
guidelines for physical activity. However, 66.9% are meeting guidelines for fruit and
vegetable intake, and 62.0% report never smoking. Despite the sample reporting an average
of nearly two chronic conditions in addition to cancer and BMIs within the overweight range,
breast and colorectal survivors reported their perceived overall health to be good at 3.1.
Confirmatory Factor Analysis
Our CFA assessed the adequacy of the hypothesized measurement model consisting
of two latent variables and six manifest variables (Figure 2). As illustrated in Table 3, the
proposed measurement model fit the data adequately well. Physical activity and
fruit/vegetable intake loaded significantly onto health behaviors. Although smoking did not
have a significant factor loading, the item was retained. The standardized factor loadings for
the items loading onto physical health latent variable were statistically significant and above
0.45, suggesting that all indicators were moderately correlated with the latent factor with
which they were hypothesized to be related. Next, we examined the intercorrelations between
the latent constructs and found there to be a significant correlation between physical health
and health behaviors. The strength of the correlation between the two latent variables
suggests that the constructs hypothesized to represent distinct phenomena are closely related
and may not be distinct. As a result, health behaviors and physical health served as the final
outcomes of the hypothesized structural model.

Final Structural Model
We tested the full hypothesized structural model and found that the model did not fit
the data well, and the total and direct effects of SCPs to proximal and distal outcomes was
not significant. As a result, receipt of an SCP was removed from the final structural model,
and PCC served as the primary predictor. The results of the final structural model with the
standardized regression coefficients are presented in Figure 3. Table 4 provides the overall fit
statistics and the standardized direct, indirect, and total effects of the final model.
The overall fit statistics indicate that the model fit the data adequately with a chisquare of 28.379 (df = 16, p-value = 0.03), RMSEA = 0.07, CFI = .88, and WRMR = 0.73.
PCC had a significant direct effect on health self-efficacy and physical health but not on
health behaviors. Health self-efficacy had a significant direct effect on physical health and
health behaviors, but we did not find any significant indirect effects via health self-efficacy.
Since the indirect effect of PCC on physical health via health self-efficacy was approaching
significance and the significant direct effect of PCC on physical health was borderline, we
tested the structural model in a larger sample of breast and colorectal cancer without
restricting for completion of treatment (Appendix D). The point estimates in both models
were similar, but the p-values for the direct effect of PCC to physical health was no longer
significant while the indirect effect via health self-efficacy was significant. This finding
suggests that the effect of PCC on physical health may be completely mediated by health
self-efficacy.
Discussion
To our knowledge, these analyses are the first attempt to simultaneously test
hypothesized pathways linking the receipt of an SCP to proximal and distal outcomes at a

survivor-level using a nationally representative sample of colorectal and breast cancer
survivors. We identified latent measures for health behaviors and physical health and tested
an a priori conceptual model that adapted Parry’s framework for Survivorship Care Planning
Research by incorporating Lafata’s Patient-Clinician Communication Model to clearly define
hypothesized pathways linking SCPs to proximal and distal survivor-level outcomes. SEM
allowed us to test multiple relationships simultaneously within a conceptual model where
mediating variables are suspected of having complex intercorrelations. However, future
prospective studies are needed to account for the complexities of these relationships and
further delineate potential causal pathways.
Overall, we found that the receipt of an SCP did not have a significant total or direct
effect on any outcomes identified in our conceptual framework. This finding is consistent
with published research suggesting that receiving an SCP alone is not likely to influence
survivor-level outcomes.12,13 Yet, researchers continue to call for more research to identify a
core set of proximal outcomes on SCPs that includes measures of patient knowledge, patientprovider communication quality, and understanding of provider roles.13 Null findings may be
due to the limitations of the HINTS survey item serving as a proxy of SCP receipt and the
inability to measure immediate outcomes of SCP receipt such as knowledge in survivorship
care that may be antecedent to and inform subsequent communication exchanges. The timing
between the receipt of an SCP with completing cancer treatment may also contribute to null
findings. It is possible that the survivors do not remember if they received a care plan or did
not receive a care plan because respondents completed treatment prior to the CoC mandate
for SCP delivery. Besides, the impact of SCPs may be lost as part of the information

exchange captured by the PCC items. Therefore, future studies should assess proximal
outcomes of SCP delivery in survivors who recently completed active treatment.
Results from this study emphasize the role of PCC in survivorship care and build
upon the evidence regarding the mechanisms through which PCC affects survivor-level
outcomes. Aligned with the framework proposed by Lafata et al., we found that PCC had a
significant direct effect on health self-efficacy and physical health.25,45 We also found that
PCC may contribute indirectly to physical health via health self-efficacy.25 High-quality PCC
will remain essential as medical payment programs consider care team communication as an
indicator of patient-centered care.45-47 Engaging in the six core functions of PCC is
particularly important to the quality of the care experiences of survivors, who face challenges
relating to the management of late and long-term effects.25,30,45,48 Given the importance of
PCC in improving cancer care quality and outcomes, future interventions of survivorship
care planning should focus on improving communication between the survivors and care
teams.
Survivors are becoming increasingly responsible for self-managing their health by
reducing the impact of consequences due to the cancer and its treatment on functioning in
daily life and for adopting behaviors that can facilitate recovery and to minimize late effect
risks.49,50 Health self-efficacy is central to survivors managing the consequences of cancer
and its treatment, understanding how and when to seek support, recognizing and reporting
signs and symptoms, and adhering to lifestyle and clinical recommendations that promote
survival. 51-53 Consistent with published research, we found that health self-efficacy had a
significant direct effect on lifestyle behaviors and physical health.51,54,55 Although
interventions promoting self-management exist aimed at increasing survivors’ self-efficacy,

few are facilitated by care teams.56 Future research should explore ways to integrate selfmanagement interventions into the survivorship care planning process to promote
improvements in long-term outcomes.
Strengths and Limitations
This was a cross-sectional study limiting our ability to make causal inferences from
our findings or account for the timing of the exposure, mediators, and outcome variables. We
assumed all variables were stable moving in a single direction, although the relationship of
some variables may be bidirectional. The HINTS survey is also self-report, potentially
resulting in over-reporting and recall bias. Our sample size also limited our ability to test
meaningful differences in the structural model by subgroups. Future studies should measure
outcomes identified in this study and assess differences in the structural model by cancer site
and within underrepresented populations who bear a disproportionate burden of cancer and
challenges following active treatment.
The variables and responses coded in the HINTS dataset may not capture the
complexity of outcomes or the relationship among variables. Our measure of health selfefficacy consisted of a single item that was broadly applicable to one’s overall health. Selfefficacy is a general trait that is likely to change based on the task to be self-managed and is
subject to change over time. Moreover, the PCC items utilized in this study may not
comprehensively capture the complexity of the six core functions of PCC in cancer
survivorship. The PCC items also do not specify whether survivors are reporting
communication and care experience with oncologists or other types of healthcare providers.
In addition, this study is limited by a lack of data on provider characteristics such as length of
relationship with a provider, important for establishing trust and rapport.

Despite these limitations, our findings are useful for exploratory analyses to generate
hypotheses and explore the use of SEM in epidemiological studies. The HINTS dataset is
also one of the few publically available datasets with comprehensive measures associated
with survivorship care. Finally, the items within the HINTs dataset are also applicable to
one’s health and healthcare experience more broadly.
Conclusion
A better understanding of the complex relationships between SCPs and survivor-level
outcomes is critical as we continue to improve survivorship care and has implications for
organizations allocating time and money to the development and receipt of SCPs. To this
end, it may be time to move beyond studies that look at SCPs in isolation and instead conduct
research in which SCPs are embedded in evaluating the effectiveness of different models of
survivorship care.13,23 This study examined a conceptual framework among a nationally
representative sample of cancer survivors and identified PCC and health self-efficacy as
potential target areas for future interventions that may influence long-term health outcomes.
Finally, our findings help to inform the selection of more appropriate outcomes for
measuring the impact of SCP delivery. More proximal outcomes of SCP delivery may
include understanding of survivorship issues or a greater amount of information received.57
SCP may also impact specific aspects of PCC such as the communication exchange but is
unlikely to facilitate changes in health self-efficacy, adherences to health behaviors, or
overall physical health. Future studies should continue to explore the underlying mechanisms
linking the process of survivorship care planning to survivor-level outcomes, in samples that
reflect the diversity in survivor populations and clinical settings.

Tables and Figures for Paper 1
Tables for Paper 1
Table 1. Respondent Sociodemographic, Clinical, and Cancerrelated Characteristics
N (Weighted %a)
Cancer Type
Breast
158 (73.8)
Colorectal
54 (26.2)
Time Since Completing Treatment
< 1 year
19 (10.0)
1-5 years
57 (23.1)
5-10 years
59 (26.2)
> 10 years
77 (40.7)
Gender
Male
24 (8.7)
Female
184 (91.3)
Age Group
18-49
8 (3.1)
50-64
70 (37.9)
65-74
69 (27.2)
75+
60 (31.8)
Education
Less than High School
25 (14.8)
High School Graduate
57 (27.6)
Some College
61 (28.7)
College Graduate or More
66 (28.8)
Race
NH White
132 (82.1)
NH Black
32 (2.8)
Hispanic
15 (1.1)
NH Other
11 (1.4)
Income
Less than $20,000
54 (25.1)
$20,000 to < $35,000
37 (17.4)
$35,000 to < $50,000
24 (8.7)
$50,000 to < $75,000
28 (19.3)
$75,000 or More
43 (29.5)
Health Insurance
Yes
199 (95.0)
No
10 (5.0)
a
Sample and replicate weights were applied to account for the
complex survey design and to ensure estimates are representative of
the US population. Some values may not equal 100.

Table 2. Description of HINTS Variables
Mean (SE) or Frequency (Weighted
%a )
Receipt of SCP
Yes
86 (38.1)
No
123 (61.9)
Patient-Centered Communicationb
20.7 (0.3)
Health Self-Efficacyc
3.7 (0.1)
Lifestyle Behaviors
Aerobic physical activity
0 min/week
84 (39.6)
0-149 min/week
76 (32.7)
>150 mins/week
51 (27.7)
Fruit/Vegetable Intake
< 3-5 servings/day
84 (33.1)
> 3-5 servings/day
128 (66.9)
Tobacco Use
Never
128 (62.0)
Former or Current
82 (38.0)
Physical Health (PH)
Body Mass Index (BMI)
28.7 (0.9)
Number of Chronic Conditions
1.7 (0.1)
Self-reported Physical Healthc
3.1 (0.1)
Abbreviations: SD, Standard Deviation
a
Sample and replicate weights were applied to account for the complex survey design and to ensure
estimates are representative of the US population.
b
Overall score of the sum of six items on a 4-point likert scale with higher scores indicate higher values on
construct (range of scores 9-24)
c 5-point likert scale with higher scores indicating higher values on construct (range of scores 1-5)

Table 1.3 Standardized Factor Loadings for Latent Structure for
Lifestyle Behaviors and Physical Health
Parameters
17
Fit Indices
Chi-Square p-value
0.23
RMSEA
.04
CFI
0.96
WRMR
0.49
Standardized Item Loadings
b (SE)
Health Behaviors (HB)
PA
0.96 (0.18)***
Smoke
0.12 (0.16)
FV
0.45 (0.13)***
Physical Health (PH)
Self-reported health
0.59 (0.10)***
BMI
-0.47 (0.12)***
# of Chronic Conditions
-0.65 (0.08)***
PH with HB
0.63 (0.15)***
* P-value < 0.05
*** p-value < 0.01

Table 1.4 Standardized Total, Direct, and Indirect Effects for Paper 1
b (SE)
Patient-centered communication to Physical Health
Total effect
0.34 (0.11)
Indirect effect
0.11 (0.06)
Direct effect
0.23 (0.12)
Patient-centered communication to Health Behaviors
Total effect
0.27 (0.12)
Indirect effect
0.09 (0.07)
Direct effect
0.18 (0.13)

p-value
<0.01
0.06
0.05
0.02
0.21
0.14

Figures for Paper 1
Figure 1. Hypothesized pathways linking SCPs to Proximal and Distal Outcomes

Figure 2. Hypothesized Measurement Model for Health Behaviors and Physical Health

Figure 3. Standardized results for the final structural model

Notes: *significant at p < 0.05
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Introduction
Breast and colorectal cancer survivors represent two of the most prevalent cancers in
females and comprise nearly a third of the total cancer survivor population.1 Cancer
survivors, defined as patients who have completed active treatment, are at increased risk for
poor health outcomes post-treatment.2-4 Under- and un-insured patients, such as those served
by safety-net settings, bear a disproportionate burden of cancer and experience disparities in
survivorship outcomes due to suboptimal patient-provider communication, inadequate
supportive resources, and low access to and awareness of health information resources.5,6
The Institute of Medicine (IOM) report From Cancer Patient to Cancer Survivor:
Lost in Transition, has sought to establish the essential elements of any model of
survivorship care planning: surveillance for recurrence, screening for secondary cancers,
assessment and intervention for long-term/late-effects, counseling on healthy lifestyle
behaviors, and communication/coordination with primary care.7 Several models of
survivorship care exist directed toward a common goal of improving the quality of
survivorship care following the completion of active treatment.6,8 Routine delivery of a
survivorship care plan (SCP) remains the dominant approach of most models, where delivery
is intended to facilitate communication between patients and providers and amongst
providers.7,8,9 In the decades following the release of the IOM report, several high-profile
organizations have mandated the delivery of SCPs concluding that SCPs have strong face

validity as a tool for navigating post-treatment care.7,9 In fact, qualitative studies with underand underserved cancer survivors found SCPs to be acceptable and helpful following the
completion of active treatment.10,11
A number of previous studies have examined the effectiveness of SCPs on health and
health care outcomes with mixed results.12 Observational studies have attributed a positive
effect of SCPs on survivor-level outcomes including satisfaction with care13, patient-provider
communication14,15, confidence in one’s ability to manage care (self-efficacy)16, and to
changes in lifestyle behaviors.17 However, findings from randomized controlled trials show
no effect on patient-reported health states and perceptions of care.18,19 Among the few
significant findings in RCTs, results suggest that SCPs may beneficially affect health
worry20, information received21, and satisfaction with care.22
Inconsistencies in SCP effectiveness may be partly due to variation in outcomes
measured across studies and a limited understanding of the types of outcomes that SCPs are
likely to influence.23,24 Moreover, much of the research around SCPs have focused on
addressing informational needs by improving the content, use, and delivery of SCPs; few
examine the survivor’s own perspectives regarding the care planning experience.11 To this
end, more work is needed to identify and refine the survivor-level outcomes most relevant to
patients, notably with more diverse populations and settings.23-26 Importantly, outcomes
should be “patient-centered”, capturing the most relevant health effects and other
consequences following cancer treatment.23,25,27 Therefore, the objective of this paper is to
elucidate the survivor’s experience with survivorship care planning and elicit perspectives
about relevant outcomes among breast and colorectal cancer survivors receiving care at a
large, urban integrated safety-net health system. Findings from this paper may help to inform

new models of survivorship care by elucidating possible mechanisms through which SCPs
and care planning process impact outcomes and by identifying key targets for future
interventions.
Methods
Study Design
We employed a qualitative research design and invited a purposeful sample of
colorectal and breast cancer survivors to participate in a 30 minutes semi-structured
telephone interview. We drew this sample from those currently enrolled in a larger quasiexperimental hybrid implementation-effectiveness study (NCI R01CA203856- Project
CONNECT) of evidence-based care coordination strategies for patients with pre-existing
chronic conditions and an incident cancer diagnosis. This study was approved by the
University of Texas Southwestern Medical Center, Parkland Health & Hospital System
Office of Research Administration, and the University of Texas Health Science Center at
Houston Institutional Review Boards (IRB).
Recruitment and sample
Participants were recruited from a large, urban county integrated safety-net health
system in Texas accredited by the American College of Surgeons Commission on Cancer,
thus mandated to provide all survivors with an SCP, making them an ideal population for
understanding experiences with survivorship care planning. Safety-net providers serve
patients regardless of their ability to pay, whose patient mix includes substantial numbers of
uninsured, Medicaid, and other vulnerable populations.28 Using electronic health record data
and registry data, we identified patients diagnosed with stage I, II, and III breast or colorectal
cancer who completed active treatment in the last 18 months. We defined the completion of

active treatment as the completion of initial surgical treatment and/or initial adjuvant
chemotherapy and radiation. Those with in situ (stage 0) and metastatic disease (stage IV)
were excluded because they are unlikely to receive a SCP. Those with impaired hearing or
speech and/or the inability to comprehend or speak English, were also excluded from
participation. We identified 26 eligible participants who completed a survey about their
cancer care experience and indicated that they were interested in completing a follow-up
interview with the research staff.
Procedure
A non-proportional quota sample was chosen from eligible participants who
expressed an interest in taking part in an interview with the research team. Initially, research
staff aimed to recruit a diverse sample of survivors to examine potential differences in posttreatment experiences and outcomes by cancer site (50% Breast, 50% Colorectal).
Participants were selected to populate the cancer site subgroup with the aim of recruiting a
maximum of 10 participants who completed treatment in the last 18 months. Between May
and July of 2019, we reached out to 22 eligible participants for an interview and completed
nine interviews (eight women and one male). Due to challenges recruiting males and a
limited number of colorectal patients meeting eligibility criteria, the team made the decision
to limit the sample to women only to increase the potential to reach saturation. The sampling
strategy was modified to represent the demographic and cancer related distribution of breast
and colorectal cancer survivors at the county system (70% racial/ethnic minorities, two-thirds
breast cancer). All interviews acquired informed consent and were performed using a semistructured interview guide by a trained member of the research staff. Interviews were audiorecorded and transcribed verbatim. Participants were compensated $20 for their time.

The interview guide was informed by our conceptual framework that integrated Parry
et al. model of Survivorship Care Planning Research with Lafata et al. model of PatientClinician Communication and further included pathways identified in observational studies
linking SCPs to proximal and distal survivor-level outcomes (Figure 1). Parry et al. proposed
a clinical framework based off the landmark IOM report in which SCPs facilitate patientprovider communication, in turn, resulting in improvements in survivor-level outcomes, such
as management of late effects, and long term physiological and psychosocial outcomes.25
Given that recommendations for SCPs explicitly state that communication between patients
and providers, or “patient-centered communication” (PCC), is central to delivering highquality survivorship care,9 we included Lafata et al. conceptual framework that suggests that
the communication exchange between the patient and provider may result in improved health
outcomes, primarily indirectly through affective-cognitive outcomes, such as health selfefficacy, and behavioral outcomes, such as physical activity and diet.29,30 Finally, our
conceptual framework also includes two direct pathways supported by observational studies
linking SCPs to increased confidence in one’s ability to manage care and changes in health
behaviors.16,17
Our semi-structure interview guide was informed by this integrated conceptual
framework and focused on the women’s experience with survivorship care planning and their
experience following the care planning visit. We asked women to reflect on their last
treatment visit with their oncology care team to understand their experiences with
survivorship care planning. Specifically, we asked the women to recall the information they
received and discussed with their oncology care team during their last treatment visit. To
elucidate potential outcomes of survivorship care more broadly, we asked participants to

describe their post-treatment experience. We probed participants to discuss how they knew
they were doing well post-treatment and to identify the most important thing they could do to
stay healthy after cancer treatment. See Appendix B for the final interview guide.
Analysis
All data was professionally transcribed, de-identified, and analyzed in NVivo (QSR,
International, AUS). Two members of the research team performed thematic content analysis
using a deductive-inductive approach.31 Each transcript was first reviewed in its entirety to
allow themes and subthemes to emerge. Then, drawing on constructs from our conceptual
model, we developed a deductive code structure that was applied to three transcripts during
an initial open coding session. As new ideas emerged, the research team considered inductive
themes and domains, allowing the codebook to evolve.32,33 The revised codebook was then
applied to the five remaining transcripts. The team coded the transcripts independently before
coming together to compare codes. All discrepancies in codes were resolved through
consensus and analysis continued until no new ideas emerge from subsequent interviews and
resulting themes were deemed saturated.34
Results
We analyzed a total of eight interviews with female breast and colorectal cancer
survivors who completed treatment in the last 18 months. Table 1 outlines their demographic,
clinical, and cancer-related characteristics. The women were between the ages 49-70 (mean
57 years), approximately two-thirds were non-Hispanic (NH) black. Only one woman had
Medicare insurance, seven were on Medicaid or were uninsured (receiving some form of
county medical assistance), and most had a diagnosis of hypertension and diabetes that predated their diagnosis of cancer.

Analysis of the eight transcripts identified four overarching themes, which subsumed
several domains as shown in Table 2. Our themes can be divided into two main categories themes specific to the process of survivorship care planning and themes related to
survivorship following the care planning visit. We defined the survivorship care planning
visit as the last treatment visit with the oncology care team when survivors should be
receiving and reviewing an SCP. We also identified three inductive themes that provided
insight into additional outcomes and future targets of survivorship care research. A
description of themes and domains with supporting quotes can be found in Appendix E.
Experiences with Survivorship Care Planning
Patient-Provider Communication
We asked the women to reflect on their last treatment visit, at which survivorship
care planning should take place, with their oncology care team focusing on the last
communication exchange and the information they received to characterize relevant survivorlevel outcomes of survivorship care planning. All women reported that they had a positive
communication experience with their oncology care team.
Giving Information – Verbal and Written
We asked the women what their oncology care team told them during the last
treatment visit, and if they received any written information without explicitly asking about
SCPs. The women describe how a member of their oncology care team performed a physical
exam and provided updates on their physical condition related to the cancer treatment and
reviewed the next steps in their cancer care. The women also reported that their oncology
care team provided them with written information to take home and reviewed the information
during the visit.

They [oncology providers] provided me with the information. Not just tell
me, they also gave me the printout of what I needed to do and how I needed
to take care of myself and what to expect (49 year old, NH black, stage III
colorectal cancer survivor).
[The papers] you know, stuff like if I’m hurting or sore and it showed me
how to take care of the wound that I had on my stomach, and if I have any
problems, I call the nurse if I feel pain. (53 year old, NH black, stage II
colorectal cancer survivor).
According to the women, the paperwork they received during their last treatment visit
included information such as upcoming appointments, contact information, instructions on
how to take care of oneself, and a list of possible symptoms that warrant their attention.
Although the women did not explicitly state that they received an SCP, they did find the
written information they received to be helpful by serving as a reminder for upcoming
appointments. However, it was unclear if the written information included cancer
surveillance guidelines although a few women reported knowing they needed to attend
follow-up appointments to make sure the cancer did not return.
Eliciting Questions or Concerns and Ensuring Patient Understanding
We further probed the women to see if they felt comfortable asking questions and if
their oncology care team ensured that they understood the next steps in their cancer care.
She [provider] actually go over it with me and then ask me if I have
questions about what she just talked about and if I have a question, I’ll ask
her (59 year old, NH black, Stage III breast cancer survivor).

I’ll talk to the oncologist and then she’ll say- do you understand?- and I’ll
be like- Yes. And she’ll say- Okay, well explain to me what I told you (54
year old, NH white, stage I breast cancer survivor).
The women described how their oncology care team would review the information and then
elicit questions about the information they received. The women also reported that that their

oncology care team ensured that they understood the information provided by asking them
directly or by having them repeat back what was discussed. Finally, the women reported that
their oncology care team sent them home with a list of individuals to contact if they have any
additional questions or concerns.
Responding to Patients Needs and Care Team Responsiveness
We asked the women if their oncology care team responded to feelings of uncertainty,
stress, worry, and overall needs during their last treatment visit. The women describe how
their oncology care team showed interest in and sensitivity to their needs by providing
ongoing support and encouragement. The women emphasized how the emotional support
from their oncology care team helped to alleviate negative feelings or worries about the next
steps in their care. The women also stated that it was important for their oncology care team
to be available for questions or concerns outside of the last treatment visit and appreciated
when they received a timely response.
I was scared and I told my doctor and they said- We at [hospital], we’re
always going to take good care of our patients and that’s what I like to
hear. If a doctor to tell me that, I’m not scared no more (53 year old, NH
black, stage II colorectal cancer survivor).

...she called me back when she did it, and she actually faxed it all for me
and called me and let me know that I could come and pick up the original if
I needed it. So she’s pretty good about following up with anything I need
(59 year old, NH black, Stage III breast cancer survivor).
Challenges in Communication
Although the women generally reported positive communication experiences during
the last treatment visit, a few women did report challenges communicating with oncology

and non-oncology providers outside of the care planning visit. One woman described how
she did not like seeing different oncologists or “interns” at each visit and two women
described their frustration with non-oncology care team members, such as primary care
providers, not being informed about their cancer treatment.
Well, he just needs to be informative, my primary care physician. I mean I
know he sees a lot of people, but he’s like- Oh, okay well what did they
[oncology] say? Well, you should know what they said (52 year old, NH
black, stage III colorectal cancer survivor).
Oncology Care Team Responsibilities
We asked the women what their oncology care team can or are currently doing to
help them stay healthy post-treatment. The women stated that their oncology care team was
helping them stay healthy post-treatment by scheduling appointments and ordering the
necessary labs/radiology based on their needs. In addition, the women reported that their
oncology care team would refer them to non-oncology care team members, local support
groups, financial assistance programs, and exercise and nutrition resources as needed.
She’s got all these appointments scheduled for me, all this lab work
scheduled for me ... (54 year old, NH white, stage I breast cancer
survivor).
He sets up the appointments I ask for and stuff, and he gets to the bottom of
the problem. If he can’t, he sets you up with somebody else that can (56
year old, NH white, stage II breast cancer survivor).
Experiences and Outcomes of Survivorship Care
Post-Treatment Experience
The women were asked to reflect on their experience since their last treatment visit to
identify relevant outcomes of survivorship care overall and to understand the impact of
survivorship care planning on more distal outcomes. The women’s description of their post-

treatment experiences comprised three broad domains: 1) physical and mental health
symptoms, 2) returning to normal daily living patterns, and 3) unexpected experiences.
Physical and Mental Health
The women primarily described their post-treatment experience as the presence or
absence of physical symptoms resulting from cancer and its treatment. The most common
physical symptoms experienced included pain, swelling, and fatigue.
Well, I got a lot of other problems other than that so I still stay tired a
lot…Yeah from my- and my bones hurt and stuff like that, but it’s not from
the cancer. It’s from everything else that’s wrong with me (56 year old, NH
white, stage II breast cancer survivor).
The women also acknowledged the presence of symptoms related to their other chronic
conditions but made efforts to distinguish between symptoms related to cancer versus
symptoms due to other chronic conditions. The women did not openly discuss their mental
health symptoms until probed by the interviewer. When probed, seven out of the eight
participants reported that they were not currently experiencing mental health symptoms.
However, two out of the seven reported poor mental health following initial diagnosis or
immediately following treatment and one woman reported that she was currently
experiencing poor mental health symptoms.
Mentally, uh not very good...Not very good, and I think it’s mostly because
of not knowing, you know, what the mastectomy would actually look like
(59 year old, NH black, Stage III breast cancer survivor).
The women characterized mental health symptoms as the presence or absence of stress,
worry, anxiety, and depression and stated that the presence of mental health symptoms was
often a result of unexpected side effects of cancer and its treatment.
Unexpected Experiences

We asked the women if anything unexpected occurred following the end of their
cancer treatment. The women reported that their oncology care team prepared them for life
post-treatment by telling them what to expect. Despite being informed about the side effects
of cancer and its treatment, about half of the women reported that they were not prepared for
the severity and longevity of symptoms they experienced.
You hear about going through the chemo and all the side effects and I
guess I didn’t expect it to be as bad as it was with the side effects for the
chemo, but I mean I knew about them, I just had never personally
experienced them so I wasn’t ready for those side effects like the hair loss,
the nausea, the vomiting. I wasn’t expecting it to be as bad as it actually
was (54 year old, NH white, stage I breast cancer survivor).
Return to Pre-Cancer Function
The women were asked how they knew they were doing well following cancer
treatment. The women reported that an indicator of doing well after treatment was the return
to pre-cancer function. The women describe pre-cancer function as the reduction of
symptoms and being able to do the things they used to before their cancer treatment such as
daily living activities and returning to work.
Well, so far I’m doing fine. I don’t have no symptoms or nothing. No bad
symptoms or nothing…I went back to work and everything (49 year old,
NH black, stage III colorectal cancer survivor).
Adherence Behaviors
We asked the women what they felt was the most important thing they could do to
stay healthy following cancer treatment, and all described the need to engage in adherence
behaviors including activities that fall under cancer surveillance and healthy lifestyle
behaviors.
Engaging in Cancer Surveillance and Healthy Lifestyle Behaviors

The women acknowledge the importance of engaging in cancer surveillance
behaviors, such as attending follow-up appointments and receiving appropriate
labs/radiology to ensure that the cancer did not return or spread. Many describe engaging in
cancer surveillance activities as doing “exactly what the doctors and them tell me to do”.
Well, I need to continue with all of the follow-ups. I need to have my CT
scans done on a regular basis to make sure that none of it has gotten any
larger and that it’s not in other places, things like that (54 year old, NH
white, stage I breast cancer survivor).
I gotta take my pills for five years. I can’t run out of them. I always get
them, and I take one every- one a day (70 year old, NH black, breast
cancer survivor).

The women did not specify who was responsible for which aspects of these cancer
surveillance activities. Interestingly, the women did not mention the management of other
chronic conditions as part of cancer surveillance.
The women also discussed the importance of engaging in healthy lifestyles behaviors,
such as diet, exercise, and smoking cessation to their overall health following cancer
treatment. Specifically, the women stated that they were currently engaging in at least one
behavior and emphasized the importance of eating right and exercising to reach or maintain a
healthy weight.
So yeah just walking, just light general exercise…not overeating and I’ve
started to lose some weight now. Let’s see- yeah, I’m just making healthy
choices food wise and exercise wise or movement wise (65 year old, NH
white, stage I breast cancer survivor).
The women also acknowledged that their oncology care team and other non-oncology
providers discussed the importance of maintaining a healthy weight and engaging in healthy

lifestyle behaviors to their health. However, the women did not specify when the care team
made these recommendations and if they reiterated these recommendations during the
survivorship care planning visit. A few women did report that despite being told to exercise,
diet, or quit smoking, this did not always translate to the desired behavior.
... because I mean they’ve always told me from the time I had my daughter
that I needed to lose weight, and I just never did it so and I mean I’ve
known that I needed to cut down on the sugar and the sweets and the cokes
and things like that and there again, I didn’t do it. It was my choice not to
do it so I can’t say that there’s any experience that I’ve had that I wasn’t
really prepared for (54 year old, NH white, stage I breast cancer survivor).
Barriers to Engaging in Adherence Behaviors
We probed the women to discuss anything that made it difficult for them to engage in
healthy lifestyle and cancer surveillance behaviors. The women identified a number of
barriers including a lack of or changes in health insurance, declines in physical health due to
other chronic conditions, lack of social support, and transportation.
I’m not able to afford health insurance so that would be my only thing
about me being able to follow up with my health, you know, because of the
financial part of it but, you know, I have to worry about that when it
happens. (59 year old, NH black, Stage III breast cancer survivor).
Potential Patient-Outcomes of Survivorship Care and Care Planning
We asked the women if they felt good about their ability to manage their health
following cancer treatment, or their cancer management self-efficacy. The women generally
felt good about their ability to manage their cancer health because they were more aware of
the signs and symptoms of cancer and that their oncology care team gave them the “tools”
they needed to take care of their health after cancer. In addition, the women described the
role of social support and motivation in managing their health after cancer treatment.

Specifically, the women discussed how going through cancer treatment gave them the
motivation they needed to stay healthy and engage in healthier behaviors so that they could
be around for family and friends. The women also described the importance of having social
support from family, friends, and oncology care team members to assist with daily living
activities, encouraging healthy lifestyle behaviors, and providing ongoing information and
support.
So I got a motivation. Motivated to stay healthy enough to where I’ll be
around for a while (56 year old, NH white, stage II breast cancer
survivor).
They both work, we’re roommates so there’s- like last night. I couldn't
cook. I was nauseous, you know, hey- y’all are going to have to cook. Yeah,
so that’s just how it works around here when I get sick, I start slowing
down, and they’re like- I think you need to go get checked out (56 year old,
NH white, stage II breast cancer survivor).

Characterization of Survivor-Level Outcomes
Based on the analysis of interview data, we characterized survivor-level outcomes of
survivorship care into two broad categories - outcomes related to the process of the
survivorship care planning and outcomes following the survivorship care planning visit that
require complex behavior change. The outcomes listed in Table 3 are not exhaustive but lay
the foundation for refining the selection of the most appropriate and salient outcomes for
measuring the effectiveness of survivorship care models and interventions.
Discussion
This paper sought to elucidate the experiences of survivorship care planning among
female, safety-net breast and colorectal breast cancer survivors. Cancer survivors often feel
unprepared for life after treatment due to a lack of information about the long-term side

effects of treatment, follow-up care and surveillance, lifestyle recommendations to stay
healthy, or details related to emotional and social support.35-39 Previous qualitative studies
have primarily focused on the use, content, and delivery of SCPs in isolation and fail to
consider key elements of the planning process, such as the communication exchange between
the survivor and oncology care team.11,40,41 We were explicitly interested in elucidating
survivors' experience with the process of survivorship care planning rather than the content
and delivery of an SCP. Overall, we found that our female, safety-net breast and colorectal
cancer survivors reported positive experiences with the survivorship care planning process
and felt that their oncology care team prepared them for life post-treatment.
Our findings underscore the essential role of patient-centered communication (PCC) with
oncology care teams, not just the presence or absence of SCPs, in delivering high-quality
survivorship care planning.7,42 Several recent studies have shown that PCC following active
treatment is suboptimal, with gaps in communication most problematic among cancer
survivors with multiple chronic conditions.43-45 However, we found that female, safety-net
cancer survivors with multiple chronic conditions reported positive communication
experiences with their oncology care team that aligned with the six core functions of PCC: 1)
Fostering healing relationships; 2) Exchanging information; 3) Responding to emotions; 4)
Managing uncertainty; 5) Making decisions; and 6) Enabling patient self-management. 40-42,46
Specifically, we found that the oncology care team gave and reviewed information in a way
that was easy to understand, created an open environment to ask questions, and ensured
patient understanding using methods shown to promote knowledge and self-efficacy.47,48 The
oncology care team was also responsive to the survivors' needs, emotions, and feelings of
uncertainty during and after the survivorship care planning visit. Our findings suggest that

PCC may be critical to increasing knowledge in survivorship care, satisfaction with the
information and care received, and increasing confidence in the women’s ability to identify
signs and symptoms of cancer recurrence.30,43,47-52
This study highlights gaps in the current conceptualization of the survivorship care
planning process that have important implications for long-term health. Previous research has
primarily conceptualized survivorship care planning from a health services delivery lens;
focusing on system-level approaches to improve the delivery and receipt of SCPs to
survivors and non-oncology care team providers, such as primary care. By focusing on the
survivors’ perceived experience, the focus around survivorship care planning shifts away
from the delivery of a single document and emphasizes the role of oncology care teams in
engaging in high-quality PCC with survivors, coordinating cancer surveillance care activities,
providing practical assistance and support to overcome barriers in care, and communicating
with and coordinating care with non-oncology providers such as, primary care. These
findings emphasize the need to look beyond the delivery of SCPs in isolation and focus on
the processes of care through which survivorship care planning takes place.25
Findings from this study suggest that the survivorship care planning process alone is
unlikely to impact survivor-level outcomes that require complex behavior change. Guidelines
for cancer survivors recommend that survivors engage in multiple adherence behaviors
following the completion of active treatment.53,54 Similar to published studies, we found that
the survivorship care planning process served as “teachable moment” for oncology care
teams to discuss the importance of engaging in adherence behaviors with survivors.55,56
Previous research supports that receiving a recommendation from a provider may be a
powerful predictor of behavior change.57 However, we found that having knowledge and an

oncology care team recommendation did not always translate to the desired behavior due to a
variety of factors, such as symptom burden (e.g., fatigue, pain), physical limitations as a
result of their other chronic conditions, and sociodemographic barriers (e.g., insurance status,
transportation). These findings support existing evidence suggesting that it may be more
appropriate to assess proximal outcomes of the survivorship care planning process.24 In
addition, oncology care teams should also assess barriers to adherence behaviors and refer
survivors to interventions with a patient-level component that targets multiple adherence
behaviors.
As the focus of cancer care and control efforts shifts towards more personalized and longterm approaches, empowering cancer survivors to assume a more active role in their own
health care is becoming an increasingly essential component of cancer survivorship.58,59 Our
findings suggest effective PCC during the care planning process may promote self-efficacy in
managing long-term survivorship issues.46 Consistent with previous studies and health
behavior theory, results from this study also highlight the role of perceived social support and
intrinsic/extrinsic motivation on behavior change.60,61 We found that the women felt good
about their ability to stay healthy after cancer treatment because they felt motivated by their
cancer diagnosis and emphasized the role of perceived social support in engaging in healthy
behaviors. Future studies should continue to explore the influence of these health behavior
determinants to understand underlying mechanisms driving change and continue to explore
the influence of these determinants throughout the survivorship continuum. Similarly,
investigators may wish to explore study designs that prospectively collect data directly before
and after end of treatment visits, even recording provider-patient dialogue during these visits

to systematically document information exchange and other proximal outcomes, for example,
catching survivors on exit.
A unique feature of our study is that – drawing from a parent study in a county integrated
health system – all our cancer survivors had at least one other common chronic condition in
addition to cancer, and many acknowledge the impact of their other chronic conditions on the
burden of symptoms experienced following cancer treatment.62 Persistent symptom burden
following treatment has shown to reduce quality of life, adherence to follow-up care, and
impacts the ability for survivors to return to daily living patterns.63 Moreover, survivors may
be reluctant to discuss challenges following treatment that can contribute to psychological
distress.64 These findings support the routine collection of patient-reported outcomes that
consider the impact of chronic conditions among other sociodemographic and cancer-related
characteristics in research and clinical care to identify and control for problems that may be
overlooked within the care planning process. 62,65,66 The presence of multiple chronic
conditions also creates the added burden of managing multiple care teams even within a
county integrated system, resulting in gaps in communication between care teams and
suboptimal care coordination.7,67-69 In other settings outside of Parkland, where care is more
fragmented, oncology and primary care for survivors may be even more siloed. Our findings
allude to communication and care coordination between care teams members as an issue that
will impact all cancer survivors.70 SCPs may help to facilitate better communication and care
coordination between care teams but it is unclear from our results if non-oncology care
teams, such as primary care, are receiving a care plan and are accountable for acting on it.7
To this end, it may be appropriate to assess perceived care coordination and satisfaction with

care to account for communication and care coordination between oncology and nononcology care teams.
Although our findings represent a significant contribution to the literature, our study has a
number of limitations. The analysis of qualitative data does not allow for causal inference
and cannot be generalized to other settings caring for safety-net breast and colorectal
survivors. The nature of our interview sample limited our ability to look at other factors such
as race/ethnicity, socioeconomic, clinical, and cancer-related characteristics in a meaningful
way. Our findings may also be limited by recall bias given that survivors with multiple
chronic conditions may have trouble recalling who they saw, when, and what was discussed.
Social desirability may be another limitation since safety-net survivors may feel the need to
speak positively about the oncology care team to continue receiving quality care, although
candid reports in our study suggest this was unlikely, nonetheless social desirability was not
measured.
Despite these limitations, our study has notable strengths. Using a qualitative study
design allowed for an in-depth understanding of subtleties and complexities around the
survivorship care planning process and provided perspectives of safety-net populations that
have been underrepresented in research to date. In addition, our sample was representative of
the safety-net breast and colorectal cancer survivor population at our large urban setting and
is one of the few studies to elucidated perspectives among survivors across multiple cancer
sites. Finally, our findings may help to inform quality improvement targets for our research
setting and serve to generate hypotheses that may be tested in future target interventions and
studies.

Conclusion
To our knowledge, this is the first qualitative study focusing on the experiences with the
process of survivorship care planning among safety-net breast and colorectal cancer
survivors. We draw an important distinction between outcomes specific to the survivorship
care planning process versus outcomes of survivorship care that may require patient-level
interventions. Understanding the first-hand experiences of these survivors provided
meaningful insight into the complexities of measuring the effectiveness of survivorship care
models and emphasizes the need for ongoing assessment of outcomes that consider
implications of cancer amidst other chronic conditions, as well as the need to assess
individual-level determinants of behavior change. Finally, future studies should continue to
identify and refine the most relevant survivor-level outcomes of survivorship care planning
across diverse clinical settings.23-25

Tables and Figures for Paper 2
Tables for Paper 2
Table 1. Participants Sociodemographic, Clinical, and Cancer
Characteristics
Age (mean)
57
Race/Ethnicity
NH White
3
NH Black
5
Insurance Status
Medicare
1
Medicaid
3
Uninsured/Financial Assistance
4
Chronic Conditions
Chronic Obstructive Pulmonary Disease
2
Hypertension
7
Diabetes Mellitus
6
Heart Disease
2
Chronic Kidney Disease
1
# of Chronic Condition in addition to cancer
1-2
6
>2
2
Cancer Site
Breast
5
Colorectal
3
Stage
I*
3
II
2
III*
3
Months since end of initial treatment
6-12
7
>12
1
Provider seen at last treatment visit
Oncologist
1
Surgeon
2
Mid-Level/Nurse
3
Oncologist/Nurse
2
*Indicates that stage data was not available in the cancer registry or
electronic record for participants, thus based on self-report.

Table 2. Summary of Themes and Domains
Themes

Domains

Survivorship Care Planning

Patient-Provider Communication

Oncology Care Team
Responsibilities

Written and Verbal Information Exchange
Ensuring patient understanding
Eliciting Questions and Concerns
Making Decisions
Responsiveness
Responding to Patient Needs
Gaps in communication
Setting up appointments
Scheduling/Ordering labs/radiology
Referring to non-oncology providers and resources

Post-Survivorship Care Planning
Post-treatment experience

Adherence Behaviors
Self-efficacy

Physical Health
Mental Health
Unexpected Experiences
Return to pre-cancer function
Cancer surveillance behaviors
Healthy lifestyle behaviors
Barriers to adherence behaviors
Barriers to managing health

Table 3. Relevant Survivor-Level Outcomes
Outcomes of the survivorship care planning process
Patient-Centered Communication

Knowledge of survivorship care
Satisfaction with information received/overall care
Perceived care coordination
Perceived self-efficacya
Perceived social support (informational/emotional)

Outcomes of Survivorship
Engagement in Adherence Behaviors
• Adhering to guidelines for cancer surveillance
and healthy living after cancer
Perceived self-efficacya
Motivation to engage in adherence behaviors
Perceived social support (informational/emotional)
Patient-reported outcome measures

Figure for Paper 2
Figure 1. Conceptual Framework depicting hypothesized pathways linking SCPs to survivor-level outcomes.
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Introduction
The continual growth in the number of survivors who are living longer after cancer
coupled with the complexities of delivering comprehensive care during the survivorship
phase has generated increased attention from leading health organizations to optimize
survivorship care.1-3 The Institute of Medicine (IOM) identified four essential components of
survivorship care: 1) prevention of new and recurrent cancers; 2) surveillance for the spread,
recurrence, or development of secondary cancers; 3) management of the late and long-term
side effects of treatment; and 4) coordination between care teams.4 The use of survivorship
care plans (SCPs), as well as adherence to guidelines for survivorship, have become central
to the provision of quality oncology care.5,6
The SCP was promoted as a means of delivering patient-centered care by facilitating
communication between the oncology team and the survivors as well as communication and
care coordination between the oncology care team and primary care.4 In addition, SCPs
include information around preventive practices and recommendations for healthy living
after cancer treatment. Decades following the release of the IOM report, several high-profile
organizations, including the American College of Surgeons,7 have mandated the use of SCPs,
making them the dominant approach to models of survivorship care. Yet, evidence regarding
the effectiveness of SCPs on survivor-level outcomes remains mixed, and studies have
shown that only 39% of cancer survivors report that a provider ever discussed lifestyle

recommendations and 32% and 12% of oncologists and primary care providers respectively
report always discussing lifestyle recommendations for survivorship care with patients.8-10
Inconsistency in findings may be due to variations in outcomes measured across
studies and a limited understanding of the most appropriate outcomes that SCPs are likely to
influence.11,12 Also, few studies have focused on the context in which care plans have been
delivered, which could influence the effectiveness of SCPs on health and healthcare
outcomes.13 Researchers continue to advocate for more research to identify and refine the
most relevant survivor-level outcomes to be measured in studies examining SCPs, notably
with more diverse populations and clinical settings.11-13 Specifically, researchers have
proposed outcomes of particular focus for future research including patient-provider
communication, patient engagement through enhanced self-efficacy, lifestyle behaviors, and
overall health.14-16 However, without a guiding framework, problems are likely to persist in
identifying relevant outcomes of survivorship care planning models, as well as challenges
intervening without knowledge of the appropriate leverage points.
Few frameworks for survivorship care planning exist that depict the hypothesized
relationships through which survivorship care planning affects survivor-level outcomes.
Parry et al. proposed a clinical framework of Survivorship Care Planning in which SCPs
facilitate communication and care coordination that, in turn, influence later outcomes, such
as management of late effects, and long term physiological and psychosocial outcomes.13
However, this framework fails to consider the hypothesized indirect pathways linking
survivorship care planning to improved survivor-level outcomes, notably outcomes that
involve complex changes in behavior. Lafata et al. proposed a conceptual framework in
which the communication exchange between the patient and the provider itself can directly

lead to improved health outcomes during and after cancer and depicts how, in most cases,
communication likely affects health outcomes indirectly through affective-cognitive
outcomes, such as health self-efficacy, and behavioral outcomes, such as exercise and
nutrition. 17,18 However, neither framework incorporates health behavior theory critical for
understanding complex behavior change.
To date, few studies have utilized a comprehensive framework of survivorship care
planning and are limited in considering the survivor’s own perspectives regarding the
survivorship care planning process. Much of the research around SCPs have focused on
addressing informational needs by improving the content, use, and delivery of SCPs and have
been limited to single cancer sites.19 The purpose of this paper is to provide a high-level
synthesis of relevant survivor-level outcomes and to explore the processes behind the
delivery of SCPs. We used an adapted mixed-methods approach to integrate data from
multiple data sources and populations (Table 1) to refine existing frameworks on
survivorship care planning and suggest future research directions related to improving our
understanding survivor-level outcomes.
Methods
This study uses an adapted, mixed-methods approach. The quantitative component of
the study examined the direct and indirect relationships linking SCPs to survivor-level
outcomes in a nationally representative sample of breast and colorectal cancer survivors
using the Health Information National Trends Survey (HINTS). The qualitative component
of the study elucidates the experience with and relevant outcomes of survivorship care
planning among breast and colorectal cancer survivors receiving care at a large, urban,
integrated safety-net hospital. Due to differences in the sample composition between the two

data sources, we pulled an additional subset of colorectal and breast cancer survivors from
the initial quantitative HINTS dataset to include only non-Hispanic (NH) white and black
women with at least two chronic conditions who completed treatment in the last five years.
All three samples were included in the final analysis.
Data Collection and Analysis
We analyzed the quantitative and qualitative data separately prior to integration.
Integration of the data was informed by our conceptual framework for survivorship care
planning research adapted Parry et al. model of Survivorship Care Planning Research with
Lafata et al. model of Patient-Clinician Communication (Figure 1). Parry et al. proposed a
clinical framework in which SCPs facilitate patient-provider communication, in turn,
resulting in improvements in survivor-level outcomes, such as management of late effects
and long term physiological and psychosocial outcomes.13 Given that recommendations for
SCPs explicitly state that patient-centered communication is central to delivering highquality survivorship care,20 we included Lafata et al. conceptual framework that suggests that
the communication exchange between the patient and provider may result in improved health
outcomes, primarily indirectly through affective-cognitive outcomes, such as health selfefficacy, and behavioral outcomes, such as physical activity and diet.17,18 Finally, our
conceptual framework also includes two direct pathways supported by observational studies
linking SCPs to increased confidence in one’s ability to manage care 21 and changes in health
behaviors.22
Appendix C illustrates how we integrated survey items from the quantitative study
with interview questions from the quantitative study based on our conceptual framework.
Following integration, we reviewed all findings alongside the empirical literature to narrow

the broader conceptual framework to only include relevant outcomes and their possible
causal linkages of interest.23 Key findings from the initial quantitative and qualitative studies
are presented independently, followed by the presentation of integrated findings using a
narrative approach.24,25 The narrative approach provides intragroup comparisons of the
results from the quantitative data that are either supported or challenged by text from the
qualitative database.
Results
Summary of Quantitative Findings from Paper 1
We tested the full hypothesized structural model among HINTS respondents
diagnosed with breast or colorectal cancer who received and completed treatment for their
cancer. The model did not fit the data well, and the total and direct effects of SCPs to
hypothesized proximal and distal outcomes were not significant. As a result, the receipt of an
SCP was removed from the final structural model, and PCC served as the primary predictor.
The results of the final structural model with the standardized regression coefficients are
presented in Figure 2.
The overall fit statistics indicate that the model fit the data adequately well with a chisquare of 28.379 (df = 16, p-value = 0.03), RMSEA = 0.07, CFI = .88, and WRMR = 0.73.
PCC had a significant direct effect on all outcomes except for health behaviors, and selfefficacy had a significant direct effect on physical health and health behaviors. Although we
did not find a significant indirect effect of PCC on physical health via health self-efficacy,
the p-value is approaching significance. To this end, the full structural model was tested in a
larger sample of cancer survivors removing the restriction for the completion of active
treatment. As shown in table 2, the point estimates remain approximately the same, but the p-

values for the indirect and direct effects reverse, indicating that health self-efficacy may
completely mediate the relationship between PCC and physical health.
Summary of Qualitative Findings from Paper 2
Informed by our conceptual framework, we completed eight interviews with women
diagnosed with breast and colorectal cancer who received cancer care at a large, urban,
integrated safety-net hospital to elucidate experiences with and relevant outcomes of
survivorship care planning. Specifically, we asked the women to recall their last treatment
visit with their oncology care team as a proxy for the survivorship care planning visit. The
women were also asked to discuss their experiences since completing active treatment to
identify additional outcomes of survivorship and potential targets for intervention. We
identified four overarching themes, which subsumed several categories (Table 3) and found
that the women reported positive experiences with survivorship care planning and felt that
their oncology care team prepared them for life post-treatment.
Based on the analysis of interview data, we characterized survivor-level outcomes
into two broad categories - outcomes related to the process of survivorship care planning and
outcomes following the survivorship care planning visit that require complex behavior
change (Table 4).
Integration of Quantitative and Qualitative Data
Table 5 shows the distribution of sociodemographic, clinical, and cancer-related
characteristics across the quantitative and qualitative samples. The interview sample of
safety-net, female breast and colorectal cancer survivors was, on average, younger than the
HINTS samples, 57 years of age versus nearly 64 years of age. In addition, a larger
percentage of the interview sample was NH black (62.5) and uninsured (50.0). Finally, the
majority of the interview sample completed active treatment in the last year (87.5), while the

majority of the HINTs samples completed treatment over a year ago. Table 6 provides the
descriptive statistics for the variables of interest derived from our conceptual framework
alongside an illustrative quote from semi-structured interview findings.
Receipt of a Survivorship Care Plan
Results from the quantitative data show that the majority of breast and colorectal
cancer survivors did not receive an SCP, although the percentage of those reporting that they
did receive an SCP is higher in survivors who were less than five years from active
treatment. The female, safety-net breast and colorectal cancer survivors reported that they
received and reviewed some form of written information with their oncology care team
during the last treatment visit although they did not explicitly state that they received an SCP.
The written information provided and reviewed by the oncology care team included
information about upcoming appointments, who to contact with questions or concerns,
instructions on how to take care of oneself based on the treatment received, and a list of
possible warning signs and symptoms. The women did report that the written information
they received did serve as a helpful reminder for upcoming appointments.
Patient-Centered Communication
The quantitative and qualitative findings suggest that breast and colorectal cancer
survivors report positive communication experiences with their care teams. At a population
level, both samples of breast and colorectal cancer survivors reported high overall scores of
PCC with their healthcare providers. The interviews focused on the communication exchange
with the oncology care team during the last treatment visit. The women reported positive
communication experiences with their oncology care team and described how the oncology
care team gave them all the information they needed to stay healthy post-treatment and
communicated the information in a way that was timely, easy to understand, and responsive

to their needs and feelings. The women also reported that their oncology care team made it
easy for them to ask questions and ensured that they understood the next steps in their care.
However, the women did report gaps in communication mainly between oncology and nononcology care teams. Specifically, the women reported that non-oncology care team
members, such as primary care, were not always informed about their cancer treatment.
Perceived Self-Efficacy
Results from the quantitative data show that that breast and colorectal cancer
survivors, on average, feel confident in their ability to manage their overall health. For the
qualitative study, we asked the women if they felt confident/good about their ability to take
care of their health after cancer. The women stated that they felt good about their ability to
take care of their health after cancer because their oncology care team provided them with
the information (e.g., written information on what to look for and expect) and tools (e.g.,
supportive resources, referrals, scheduling upcoming appointments) they needed to be able to
identify signs and symptoms of cancer recurrence.
Engaging in Lifestyle Behaviors
The quantitative data across both HINTS samples show the majority of cancer
survivors are not meeting all recommended guidelines for healthy behaviors as outlined by
the NCCN, especially for minutes of physical activity. We asked the women specific
questions about their health behaviors such as minutes of physical activity per day, servings
of fruits/vegetables intake per day, and tobacco use. The majority of women were not
meeting the recommended guidelines. However, the women emphasized the importance of
engaging in healthy behaviors and reported that they were currently engaging in at least one
behavior. They also stated that despite oncology care teams and other providers
communicating the importance of engaging in healthy behaviors, this did not always translate

to the desired behavior due to a number of barriers, such as declines to physical health due to
other chronic conditions and a lack of social support. Despite these challenges, a couple of
women described how being diagnosed with cancer gave them the motivation they needed to
stay healthy after cancer treatment and several women emphasized the importance of social
support from friends, family, and oncology care teams in helping with daily living activities,
providing ongoing encouragement, practical assistance, and referrals to resources.
Physical Health
The quantitative findings show similarities across both samples of breast and
colorectal cancer survivors. Specifically, both samples, on average, rated their overall health
good, despite being overweight and having at least one chronic condition in addition to
cancer. Findings from the qualitative data may provide glimpses into this perception of
overall health. The women primarily characterized their health after cancer treatment as the
presence or absence of physical symptoms resulting from cancer and its treatment. The
women stated that the absence of physical symptoms also served as an indicator of doing
well after cancer because they were able to do the things they used to do before cancer
treatment. However, the women also acknowledged that they continued to experience
symptoms related to their other chronic conditions that at times served as a barrier to
engaging in activities that promoted overall health, such as exercise and diet.
Additional Qualitative Insights
Findings from the qualitative study provided additional insights that were not
explored in the quantitative analysis due to limitations in the HINTS datasets. In addition to
communicating to the women the next steps in care, the women emphasized the role of their
oncology care team in settings up future appointments, ordering upcoming labs/radiology,
and making referrals to non-oncology providers and resources as part of the survivorship care

planning process. The women also acknowledged the importance of doing “exactly what the
doctors and them tell me to do” to ensure that the cancer does not spread or return. In
addition, the women described the role of social support and motivation in managing their
health after cancer treatment. Specifically, the women discussed how the cancer diagnosis
served as an intrinsic motivator to stay healthy after cancer and that a recommendation from
an oncology care team member also served as an extrinsic motivator to engage in cancer
surveillance and healthy lifestyle behaviors. The women also described the importance of
having social support from family, friends, and oncology care team members to assist with
daily living activities, encourage engagement in healthy lifestyle behaviors, and provide
ongoing information and support.
Modifications to Survivorship Care Planning Frameworks
Based on the integration of findings, we propose a framework for survivorship care
planning research that builds upon existing models by depicting the direct and indirect
pathways linking the process of survivorship care planning to key survivor-level outcomes
(Figure 3). This framework is based on the survivor’s perspective of survivorship care
planning and the experience following the completion of active treatment. This framework
does not consider the influence of system- (i.e., organizational structure, capacity) and/or
provider-level factors (i.e., individual-level factors) on survivor-level outcomes.
We start on the left side of the model with the survivorship care planning visit –
defined as the last treatment visit. Based on our findings, the communication experience
between the oncology care team and the survivor is central to the survivorship care planning
process and should encompass the six core functions of PCC. The receipt of an SCP may
assist with the exchange of information - one domain of PCC – but does not replace the

communication experience. To this end, PCC is the central outcome of the survivorship care
planning visit that directly impacts proximal outcomes of the communication exchange
including knowledge in survivorship care and satisfaction with care and information
received. Effective PCC may also directly result in changes in perceived self-efficacy to
identify signs and symptoms of cancer recurrence and management in overall health. In most
cases, PCC is likely to impact perceived self-efficacy indirectly via knowledge in
survivorship care. Insights from the interviews identified that the oncology care team is also
responsible for coordinating key cancer surveillance activities and should communicate and
coordinate their plans with non-oncology care team members, such as primary care.
Therefore, another outcome of the survivorship care planning process from a survivors’
perspective may be perceived care coordination.
Our framework makes an important distinction between outcomes specific to the
process of survivorship care planning versus outcomes that require complex behavior change.
Insights from the qualitative study suggest that the survivorship care planning visit alone is
unlikely to result in changes to complex behaviors. Based on findings from the qualitative
study, we identified determinants and psychological mechanisms of behavior change derived
from health behavior theory. Perceived self-efficacy is the primary explanatory construct of
prominent health behavior theories, such as Social Cognitive Theory, due to its ability to
predict and explain who is (or is not) motivated to perform health-related behaviors.26,27 To
this end, our conceptual framework depicts a direct pathway linking perceived self-efficacy
to engage in and overcome barriers to engaging in adherence behaviors. Beyond direct links
between self-efficacy and adherence behaviors, health behavior theories suggest that any
number of motivational factors can lead people to say they “can” or “cannot” perform

specific adherence behaviors (e.g., liking/disliking exercise, expected outcomes of
performing adherences behaviors, and expected outcome of prioritizing adherence behaviors
over other competing demands).28 Our qualitative findings support the inclusion of a direct
pathway linking motivation (intrinsic/extrinsic) to adherence behaviors, as well as a direct
pathway from perceived social support to adherence behaviors, in which social support may
influence engagement of adherence behaviors through practical assistance, emotional, and
informational support.29 Based on our findings and substantial evidence in the literature
supporting the importance of adherence behaviors to overall health, we have included a direct
pathway linking adherence behaviors to overall physical health and quality of life. Finally,
our model recognizes the influence of individual-level sociodemographic, clinical, and
cancer-related characteristics on survivor-level outcomes across the survivorship continuum.
Discussion
Survivorship care plans remain an integral component of cancer survivorship care and
are regarded as a core measure of the American Society of Clinical Oncology Quality
Oncology Practice Initiative despite limited empirical evidence supporting what SCPs can
reasonably be expected to change.1,30 Optimum survivorship care encompasses cancerspecific surveillance, supportive care for late and long-term effects, management of other
chronic conditions, general preventive care, and supportive care.31 These components of care
are unlikely to be achieved in a single document. Yet, the majority of research continues to
place priority on improving the content, use, and delivery of SCPs rather than on the
survivorship care planning process. Our study is unique in that we used an adaptive mixedmethods approach to provide a high-level synthesis of data from various sources and
populations to better understand the process of survivorship care planning and to identify

more appropriate survivor-level outcomes. Overall, our study supports that SCPs cannot
stand alone in improving survivor-level outcomes if there are no mechanisms in place to
implement the plan’s recommendations. For example, most oncologists do not possess the
skills to counsel on health behaviors. As such, guideline recommendations for cancer
surveillance and healthy lifestyle behaviors incorporated into the survivorship care planning
process are meaningless unless the appropriate supportive care resources and interventions
are integrated into the standard workflow of cancer care programs.12,31,32
Our study is unique in that it goes beyond examining survivorship care planning from
a health services perspective and focuses on the survivor's experience as a key stakeholder in
the process. Most processes of survivorship care planning focus on how various stakeholders
(providers, nurses, administrators) operate and interact within the larger health care system
and the role expectations associated with those involved in the delivery and coordination of
survivorship care.13,33,34 Results from this study provide a glimpse into the potential gaps in
the survivorship care planning process and emphasize the need for patient-centered
approaches to survivorship care. First, effective PCC by the oncology care team with the
survivor is essential to delivering high-quality survivorship care planning and involves giving
and explaining information in a way that is easy to understand, eliciting questions and
concerns, ensuring that the survivor understands the next steps in their care, and being
responsive to negative emotions and feelings of uncertainty.1,35 Delivering an SCP may help
facilitate the exchange of information, but it is not a replacement for PCC. Second, oncology
care teams are also responsible for coordinating cancer surveillance activities, and engaging
non-oncology care team members in the survivor's care. Our qualitative findings support that
gaps remain in survivorship care delivery due to poor coordination and inadequate

communication between members of multi-disciplinary care teams (i.e., between oncologist
and primary care providers).4 Finally, previous frameworks of survivorship care planning
assume that the process alone is sufficient enough to drive complex behavior changes at the
survivor-level. However, our findings suggest that this is not the case and emphasize the need
to understand the influence of individual-level factors on key survivorship outcomes and
supports the inclusion of behavioral science theory into existing frameworks of survivorship
care to help predict and explain behavior change.
The basis for many barriers to providing high-quality survivorship care planning is
the lack of evidence regarding best practices that are likely to result in improved survivorlevel outcomes.1,36 Although several models of survivorship care have been proposed to
address the gaps we identified in this study; few studies have described the process or
outcomes of these models.33,34,37 The use of implementation and behavioral science theory
may provide new insights into the development and planning of comprehensive survivorship
care models. Behavioral science can assist with linking relevant causal factors of a behavior
to appropriate model components and provides valuable insight into the underlying
mechanisms driving change in survivor-level outcomes.37 Implementation science is
dedicated to promoting the uptake of survivorship care models given the complex set of
conditions and factors potentially impacting the effectiveness of models on outcomes.38
Using frameworks derived from behavioral and implementation science theory, such as
Intervention Mapping, may help to reduce gaps identified in this study by assisting
researchers and planners in clinical settings with systematically planning strategies aimed at
achieving realistic and relevant outcomes of their survivorship care planning model.39
Strengths and Limitations

Our study had several limitations. In addition to limitations previously described in
papers one and two, a notable limitation of this study is that we did not collect data from the
same sample – the most ideal approach in mixed methods research. However, collecting data
from the same sample was challenging in this instance for a number of reasons. First, few
frameworks of survivorship care planning exist, and the generation of relevant survivor-level
outcomes at a population level is relatively unknown. Second, there is lack of items related to
survivorship care planning in national-level datasets and a lack of validated measures to
assess hypothesized survivor-level outcomes more broadly. Thirdly, recruiting from a single
safety-net healthcare system limits the number of cancer cases resulting in small sample sizes
and insufficient power to test relationships. Finally, limitations in the HINTS dataset did not
allow for testing of the modified conceptual framework at a population level, and we were
unable to test meaningful differences in outcomes by subgroups.
Despite these limitations, our study has many strengths. The use of an adapted mixed
methods approach brings together the strengths and weaknesses of quantitative and
qualitative data, and the utilization of deductive and inductive approaches deepened our
understanding of the topic. In addition, data from various data sources and populations
provided a high-level synthesis of the problem that could not be described within a single
population or setting. Our study was also guided by a clear conceptual framework derived
from clinical and behavioral science to facilitate the integration of findings. The use of a
conceptual framework also assisted with the identification of potential targets for future
intervention and may inform measurement development. Although findings from this paper
limit our ability to generalize to other settings, the overall synthesis of results provides

important information to inform recommendations and hypothesis-generating direction for
future research.
Recommendations and Future Research
Based on the information summarized above, we recommend consideration of several
areas for future research on survivorship care.
1. Providing high-quality survivorship care requires an infrastructure in which
comprehensive, integrated care, according to guidelines, can be delivered. Future
research should continue to describe the setting in which care planning occurs, the
participants involved in the planning process, and the structures and processes in
place to support quality transitional care.
2. Our findings support research agendas shifting away from examining the
effectiveness of SCPs in isolation. Future research should continue to focus on
strategies to improve key elements of the survivorship care planning process such as
communication and care coordination, as well as consider the influence of individuallevel characteristics on survivor-level outcomes across the survivorship continuum.
3. Future studies should move beyond thinking about survivorship from a health
services delivery lens and begin incorporating implementation and behavioral science
theory to understand the underlying mechanisms of the survivorship care planning
process. Theory-based approaches will help to explain how and why a process or
model of survivorship care succeeds or fails in different settings and populations.
4. Researchers and cancer care programs need to systematically plan for implementation
and consider the complex set of conditions and factors that may influence the

effectiveness of their models of survivorship care and give greater consideration to
the types of outcomes that components of their survivorship model are able to change.
Conclusion
As the population of cancer survivors continues to grow, conducting research to
address knowledge gaps and barriers in survivorship care will become even more urgent. Our
study builds upon the existing knowledge base by identifying gaps in the current
conceptualization of survivorship care planning frameworks and informs the selection of and
measurement of relevant outcomes of the survivorship care planning process. Future studies
should continue to explore the most appropriate outcomes of survivorship care planning and
evaluate whether group differences in outcomes are observed. Finally, findings from this
study emphasize the need for future studies grounded in implementation and behavioral
science theory to assist researchers and cancer care programs in planning for and
implementing models of survivorship care that address realistic and relevant outcomes at a
survivor-level.
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Tables for Paper 3
Table 1. Data Sources with corresponding breast and colorectal cancer survivor populations
Data Sources
Survivor Population
Health Information National Trends
National-level estimates of breast and colorectal cancer
Survey
survivors
Interview Transcripts
Safety-net, female, breast and colorectal cancer survivors with
multiple chronic conditions
Table 2. Standardized Total, Direct, and Indirect Effects
HINTS Sample 1
(N = 212)
b (SE)
p-value
Patient-Centered Communication to Physical Health
Total effect
Indirect effect
Direct effect

0.33 (0.12)
0.12 (0.05)
0.22 (0.12)

0.01
0.02
0.08

HINTS Sample 2
(N = 273)
b (SE)
p-value
0.34 (0.11)
0.11 (0.06)
0.23 (0.12)

<0.01
0.06
0.05

Notes: Abbreviations: PCC = Patient-Centered Communication; PH = Physical Health
Sample 1 includes those diagnosed with breast or colorectal cancer who have received and completed treatment for cancer.
Sample 2 includes those diagnosed with breast or colorectal cancer.

Table 3. Summary of Themes and Domains
Themes
Survivorship Care Planning

Patient-Provider Communication

Oncology Care Team
Responsibilities

Domains
Written and Verbal Information Exchange
Ensuring patient understanding
Eliciting Questions and Concerns
Making Decisions
Responsiveness
Responding to Patient Needs
Gaps in communication
Setting up appointments
Scheduling/Ordering labs/radiology
Referring to non-oncology providers and resources

Post-Survivorship Care Planning
Post-treatment experience

Adherence Behaviors
Self-efficacy

Physical Health
Mental Health
Unexpected Experiences
Return to pre-cancer function
Cancer surveillance behaviors
Healthy lifestyle behaviors
Barriers to adherence behaviors
Barriers to managing health

Table 4. Relevant Survivor-Level Outcomes
Outcomes of the survivorship care planning process
Patient-Centered Communication

Knowledge of survivorship care
Satisfaction with information received/overall care
Perceived care coordination
Perceived self-efficacya
Perceived social support (informational/emotional)

Outcomes of Survivorship
Engagement in Adherence Behaviors
• Adhering to guidelines for cancer surveillance and
healthy living after cancer
Perceived self-efficacya
Motivation to engage in adherence behaviors
Perceived social support (informational/emotional)
Patient-reported outcome measures

Table 5. Sample Sociodemographic, Clinical, and Cancer Characteristics
HINTS Sample 1 HINTS Sample 2
(N = 212)
(N = 42)
N (Weighted %a) N (Weighted %a)
Age (mean)
63.6
63.7
Race/Ethnicity
NH White
132 (82.1)
30 (82.8)
NH Black
32 (11.0)
12 (17.2)
Other
26 (6.9)
Insurance Status
Yes (Medicare/Medicaid)
199 (95.0)
39 (94.7)
No Uninsured/Financial Assistance
10 (5.0)
2 (5.3)
# of Chronic Condition in addition to cancer
0
29 (18.4)
1-2
117 (58.7)
28 (77.14)
>2
59 (22.9)
14 (22.9)
Cancer Site
Breast
158 (73.8)
34 (81.1)
Colorectal
54 (26.2)
8 (18.9)
Months since end of initial treatment
< 1 year
19 (10.0)
10 (33.4)
1-5 years
57 (23.1)
32 (66.7)
> 5 years
136 (66.9)
Still in treatment
-

Interview Sample
(N=8)
N (%)
57.0
3 (37.5)
5 (62.5)
4 (50.0)
4 (50.0)

6 (75.0)
2 (25.0)
5 (62.5)
3 (37.5)
7 (87.5)
1 (12.5)

Table 6. Integration of Qualitative and Quantitative Data
HINTS
HINTS
Interview Sample
Sample
Sample
(N=8)
2
3
(N =
(N=42)
212)
Mean (SD) or N
Illustrative Quote
(Weighted %a )
Receipt of SCP
They [oncology providers] provided me with the information.
Yes
86
21
Not just tell me, they also gave me the uh the printout of what I
No
(38.1)
(48.4)
needed to do and how I needed to take care of myself and what
123
21
to expect” (49 year old, NH black, stage III colorectal cancer
(61.9)
(51.6)
survivor).
Patient-Centered
20.7
20.4
She’s [oncologist] given me all the tools that I need to be able to
Communicationb
(0.3)
(0.9)
take care of myself as best I can. I mean like I said, she’s got all
these appointments scheduled for me, all this lab work
scheduled for me and she’s explained the importance of all of
these things...Well, like I’ll talk to the oncologist and then she’ll
say- do you understand?- and I’ll be like- Yes. And she’ll sayOkay, well explain to me what I told you (54 year old, NH white,
stage I breast cancer survivor).
Health Self3.7 (0.1) 3.8 (0.1) I think I can take care of it by catching it, by watching out and
Efficacyc
stuff like that. So I’m aware of all that stuff now and if I feel
different things or see different things (56 year old, NH white,
stage II breast cancer survivor).
Lifestyle Behaviors
Aerobic physical
I actually exercise daily. Uh-huh, about 30 minutes. I walk (59
activity
year old, NH black, stage III breast cancer survivor).
0 min/week
I’d say [I walk] about 10 to 15 minutes a day (49 year old, NH
84
20
black, stage III colorectal cancer survivor).
0-149 min/week
(39.6)
(50.4)
>150 mins/week
76
12
(32.7)
(30.7)
51
10
(27.7)
(18.9)
Fruit/Vegetable
Um, I eat four actually [servings a day]. Mostly fruit (59 year old,
Intake
NH black, stage III breast cancer survivor).
< 3-5 servings/day 84
Oh some days I don’t get any, but I miss it when I don’t, unless
17
> 3-5 servings/day (33.1)
you consider tomato and lettuce on my hamburger...I would say
(40.6)
at least one serving of a type of vegetable a day um I try to.
128
25
Sometimes the day goes weird and I don’t (65 year old, NH
(66.9)
(59.4)
white, stage I breast cancer survivor).
Tobacco Use
I’m working to get off these cigarettes and I got stuff, you know,
Never
128
22
I buy and everything because I want to get off them cigarettes (70
Former or Current (62.0)
(46.8)
year old, NH black, stage I breast cancer survivor).
82
20
Yeah and I said at least I’m down to this where I used to be three
(38.0)
(53.2)
cartons a month. I’m down to one carton and five packs. I mean
give me some credit (56 year old, NH white, stage II breast cancer
survivor).
Physical Health
BMI
28.7
32.3
I’ve started to lose some weight now. Let’s see- yeah, I’m just
(0.9)
(2.7)
making healthy choices food wise and exercise wise or

Table 6. Integration of Qualitative and Quantitative Data
movement wise (65 year old, NH white, stage I breast cancer
survivor).
Number of
1.7 (0.1) 1.9 (0.2) Well, I got a lot of other problems other than that so I still stay
Chronic
tired a lot…Yeah from my- and my bones hurt and stuff like that,
but it’s not from the cancer. It’s from everything else that’s
Conditions
wrong with me (56 year old, NH white, stage II breast cancer
survivor).
Self-reported
3.1 (0.1) 2.9 (0.2) Um, gratefully the fatigue is lessening, and I’m able to get on
Physical Healthc
with doing things that I haven’t been able to commit to doing
because I didn’t know how long I would be fatigued. From the
beginning treatment, I can’t think of the name of that particular
drug in that chemo, a side effect of it has been neuropathy in my
fingers and toes. So that’s still lingering, but I don’t know if I’m
just getting used to it or if it’s lessening, you know, from time to
time I don’t even think about it and then like right now it’s
tingling as I’m- oh, yeah it has that tingling effect in my fingers
kind of thing (65 year old, NH white, stage I breast cancer
survivor).

Figure for Paper 3
Figure 1. Conceptual Framework depicting hypothesized pathways linking SCPs to survivor-level outcomes.

Figure 2. Standardized results for the final structural model.

Figure 3. Modified Conceptual Framework for Survivorship Care Planning
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CONCLUSION
As the population of cancer survivors continues to grow, conducting research to address
knowledge gaps and barriers in survivorship care will become even more urgent. This
dissertation sought to understand the relationship between the receipt of an SCP on key survivorlevel outcomes of survivorship care planning. Paper one tested a conceptual framework among a
nationally representative sample of breast and colorectal cancer survivors and found that SCPs
did not have a total or direct effect on key survivor-level outcomes. Rather, we identified PCC
and health self-efficacy as potential target areas for future interventions that may influence longterm health outcomes. These findings emphasized the need to move beyond studies that look at
SCPs in isolation and instead conduct research in which SCPs are embedded in evaluating the
effectiveness of different models of survivorship care.33,44
The second paper focused on the experiences with the process of survivorship care
planning among safety-net breast and colorectal cancer survivors. Understanding the first-hand
experiences of these survivors provided meaningful insight into the complexities of measuring
the effectiveness of survivorship care models and emphasizes the need for ongoing assessment of
outcomes that consider implications of cancer amidst other chronic conditions, as well as the
need to assess individual-level determinants of behavior change. Paper three provided a highlevel synthesis of all dissertation findings and builds upon the existing knowledge base by
identifying gaps in the current conceptualization of survivorship care planning frameworks and
informs the selection of and measurement of relevant outcomes of the survivorship care planning
process.

Strengths and Limitations
Although these findings represent a significant contribution to the literature, this
dissertation has a number of limitations. The cross-sectional nature of the HINTS dataset limits
our ability to make causal inferences from our findings or account for the timing of the exposure,
mediators, and outcome variables. HINTS is self-report and could potentially result in under- or
over-reporting and recall bias. The variables and responses coded in the HINTS dataset are also
limited in capturing the complexity of outcomes or the relationship among variables. In addition,
the sample size of breast and colorectal cancer survivors in HINTS limited our ability to test
meaningful differences in the structural model by subgroups. Finally, limitations in the HINTS
dataset did not allow for testing of the modified conceptual framework at a population level.
The analysis of qualitative data does not allow for causal inference and cannot be
generalized to other settings caring for safety-net breast and colorectal survivors. The size of our
interview sample limited our ability to look at other factors such as race/ethnicity,
socioeconomic, clinical, and cancer-related characteristics in a meaningful way. Our findings
may also be limited by recall bias given that survivors with multiple chronic conditions may
have trouble recalling who they saw, when, and what was discussed. Social desirability may be
another limitation since safety-net survivors may feel the need to speak positively about the
oncology care team to continue receiving quality care, although candid reports in our study
suggest this was unlikely, nonetheless social desirability was not measured.
In addition to limitations previously described, a notable limitation is that we did not
collect data from the same sample – the most ideal approach in mixed methods research.
However, collecting data from the same sample was challenging in this instance for a number of
reasons. First, few frameworks of survivorship care planning exist, and the generation of relevant

survivor-level outcomes at a population level is relatively unknown. Second, there is lack of
items related to survivorship care planning in national-level datasets and a lack of validated
measures to assess hypothesized survivor-level outcomes more broadly. Thirdly, recruiting from
a single safety-net healthcare system limits the number of cancer cases resulting in small sample
sizes and insufficient power to test relationships.
Despite these limitations, this dissertation research has notable strengths. The quantitative
findings are useful for exploratory analyses to generate hypotheses and explore the use of SEM
in epidemiological studies. The HINTS dataset is also one of the few publically available
datasets with comprehensive measures associated with survivorship care with survey items
applicable to one’s health and healthcare experience more broadly. The qualitative findings
allowed for an in-depth understanding of subtleties and complexities around the survivorship
care planning process and provided perspectives of safety-net populations that have been
underrepresented in research to date. In addition, the qualitative sample was representative of the
safety-net breast and colorectal cancer survivor population at a large, urban setting and is one of
the few studies to elucidated perspectives among survivors across multiple cancer sites. The
qualitative findings may help to inform quality improvement targets for Parkland and serve to
generate hypotheses that may be tested in future target interventions and studies.
The use of an adapted mixed methods approach brings together the strengths and
weaknesses of quantitative and qualitative data, and the utilization of deductive and inductive
approaches deepened our understanding of the topic.109 In addition, data from various sources
and populations provided a high-level synthesis of the problem that could not be described
within a single population or setting. This dissertation was also guided by a clear conceptual
framework derived from clinical and behavioral science to facilitate the integration of findings.

The use of a conceptual framework also assisted with the identification of potential targets for
future intervention and may inform measurement development. Although findings from this
dissertation is limited in the ability to generalize to other settings, the overall synthesis of results
provides important information to inform recommendations and hypothesis-generating direction
for future research.
Recommendations and Future Research Directions
Based on the information summarized above, we recommend consideration of several
areas for future research on survivorship care. These findings support research agendas shifting
away from examining the effectiveness of SCPs in isolation and advocate for research that
continues to identify and refine the most relevant survivor-level outcomes of survivorship care
planning across diverse clinical settings and evaluates whether group differences in outcomes are
observed.32,33,44
Providing high-quality survivorship care requires an infrastructure in which
comprehensive, integrated care, according to guidelines, can be delivered. There is a need to
describe the setting in which care planning occurs, the participants involved in the planning
process, and the structures and processes in place to support quality transitional care. Future
research should continue to focus on strategies to improve key elements of the survivorship care
planning process such as communication and care coordination, as well as consider the influence
of individual-level characteristics on survivor-level outcomes across the survivorship continuum.
These findings support the need to move beyond thinking about survivorship from a
health services delivery lens and begin incorporating implementation and behavioral science
theory to understand the underlying mechanisms of the survivorship care planning process.
Theory-based approaches will help to explain how and why a process or model of survivorship

care succeeds or fails in different settings and populations. Researchers and cancer care programs
need to systematically plan for implementation and consider the complex set of conditions and
factors that may influence the effectiveness of their models of survivorship care and give greater
consideration to the types of outcomes that components of their survivorship model are able to
change.

APPENDICES
Appendix A: HINTS Survey Items and Analytic Categories
Domain

Item(s)

Response scale(s)

Analysis categories

Receipt of Care
Plan

“Did you ever receive a summary document
from your doctor or other health care
professional that listed all of the treatment
you received for your cancer?”

Yes
No

2.

Patient-Centered
Communication

How often did the doctors, nurses, or other
health care professionals you saw during the
past 12 months do each of the following: (1)
Give you a chance to ask all the healthrelated questions you had? (Fostering
Healing Relationships) (2) Give the attention
you needed to your feelings and emotions?
(Responding to emotions) (3) Involve you in
decisions about your health care as much as
you wanted? (Making decisions) (4) Make
sure you understood the things you needed to
do to take care of your health? (Enabling
self-management) (5) Explain things in a way
you could understand? (Exchanging
Information) (6) Help you deal with feelings
of uncertainty about your health or
healthcare? (Managing uncertainty).

Always
Usually
Sometimes
Never

Continuous overall
score (Range 9-24)
with higher scores
indicating higher
levels of PCC.

“Overall, how confident are you about your
ability to take good care of your health?”

Completely
confident
Very confident
Somewhat confident
A little confident
Not confident at all

Continuous overall
score (Range 1 -5)
with higher scores
indicating higher
levels of selfefficacy.

Health SelfEfficacy

Aerobic physical
activity

“In a typical week, how many days do you do
any physical activity or exercise of at least
moderate intensity, such as brisk walking,
bicycling at a regular pace, and swimming at
a regular pace?”;
“On the days that you do any physical
activity or exercise of at least moderate
intensity, how long do you typically do these
activities?”
“About how many cups of fruit (including
100% pure fruit juice) do you eat or drink
each day?

Fruit
consumption

1 cup of fruit could be:
1 small apple; 1 large banana; 1 large
orange;
8 large strawberries; 1 medium pear;
2 large plums; 32 seedless grapes; 1 cup (8
oz.) fruit juice; ½ cup dried fruit; 1 inchthick wedge of watermelon”

1.

1.
0-7 days a week;

2.

Free response
3.

None
½ cup or less
½ cup to 1 cup
1 to 2 cups
2 to 3 cups 3 to 4
cups
4 or more cups

Received care
plan
Did not receive a
care plan

0 Mins
MVPA/week
Between 1-149
min
MVPA/week
150 mins+
MVPA/week

(Fruit and vegetable
consumption
combined to create
one variable)
1. Consistent with
recommended
guidelines:
eating between
1-2 cups of fruit
or more daily

Domain

Item(s)

“About how many cups of vegetables
(including 100% pure vegetable juice) do
you eat or drink each day?
Vegetable
consumption

Tobacco use

1 cup of vegetables could be:
3 broccoli spears; 1 cup cooked leafy greens;
2 cups lettuce or raw greens; 12 baby
carrots; 1 medium potato; 1 large sweet
potato;
1 large ear of corn; 1 large raw tomato;
2 large celery sticks; 1 cup of cooked beans”

“Have you smoked at least 100 cigarettes in
your entire life?”

“How often do you smoke cigarettes now?’

Response scale(s)

None,
½ cup or less,
½ cup to 1 cup
1 to 2 cups
2 to 3 cups
3 to 4 cups
4 or more cups

Yes
No
Every day
Some days
Not at all

Self-Reported
Health

“In general, would you say your health is…”

Excellent
Very Good
Good
Fair
Poor

BMI

Self-reported height and weight

Free Response

Number of
Chronic
Conditions

Has a doctor or other health professional
ever told you that you had any of the
following medical conditions:
Diabetes or high blood sugar
Hypertension or high blood pressure
A heart condition
Chronic lung disease
Arthritis or rheumatism.

Yes
No

Analysis categories

2.

1.
2.
3.

and between 2-3
cups of
vegetables or
more daily (> 35 servings per
day)
Not consistent
with
recommended
guidelines: less
than the above
levels (< 3-5
servings per
day)
Current
Former
Never

Continuous overall
score (Rang 1-5) with
higher scores
indicating higher
level of self-reported
health
Derived continuous
measure from HINTS

Items summed to
create a continuous
measure

Appendix B: Semi-Structure Interview Items
Note that this interview guide is elucidative of three major topics and that all questions may not
be asked to every patient.
Tell me what it has been like since you finished your cancer treatment.
Topic: Survivorship Care Planning Visit
1.) Did you see your cancer doctor, nurse, or other health professional at your last visit when
you finished treatment?
2.) What did your doctor/nurse talk to you about during the visit?
a. Did the doctor/nurse go over the papers with you during the visit?
3.) When you finished your treatment, did you get any papers during your last visit?
a. What did it cover?
b. What did you find most helpful?
c. What did you find to be least helpful?
d. Was there anything missing?
4.) Tell me how the papers you got from your doctor/nurse during that last visit had an effect
on how you speak with your doctor?
PCC – Thinking about the last visit
1.) What role does speaking with your doctor/nurse play when it comes to your overall
health?
2.) What can doctors/nurses do to make it easier for you to speak with them about your
needs?
3.) Did your doctor/nurse make you feel comfortable asking questions? (Fostering Healing
Relationships)
4.) Did you doctor make sure you understood the things you needed to do to take care of
your health after cancer treatment? (Exchanging Information)
5.) Did your doctor give you all the information or resources you need to help you make
decisions? (Making Decisions)
6.) Did your doctor/nurse make sure that you understood the next steps in your health after
cancer treatment? (Self-Management)
7.) Cancer patients often face uncertainties about life after cancer treatment. For example,
patients may not know what will happen, if the cancer will come back, or who to go to
for help. How well did your doctor/nurse help you deal with the uncertainties about your
cancer? (Managing Uncertainty)
8.) Did your doctor/nurse talk with you about how to cope with any fears, stress, and other
feelings you may have after cancer treatment? (Responding to Emotions)
9.) How important is it to you that your doctor/nurse speak with you in a way that lines up
with your needs after cancer treatment?
Topic: Post Survivorship Care Planning Visit – Focus on outcomes

Doctors and hospitals try to address things that they feel are important to your health after
finishing cancer treatment but I am interested in what you feel is important to your health after
cancer treatment.
1.) When it comes to your health, how do you know that you are doing well after cancer
treatment?
2.) If you had to choose the most important thing you could do to stay healthy, what would it
be and why?
a. What can doctors/nurses do to help you stay healthy after cancer treatment?
Health Self-Efficacy
1.) Do you feel good about your ability to take good care of your health after cancer
treatment?
a. Why?
b. What would make you feel better about taking care of your health?
2.) How important is it to you to feel good about your ability to take good care of your
health?
3.) What can doctors/nurses do to make you feel better about taking care of your health?
Lifestyle Behaviors
1.) How many minutes of exercise do you get per week?
2.) How many servings of fruit and vegetables do you eat per day?
3.) Do you smoke?
4.) Did you see a doctor within the last year for a routine check-up?
5.) How important is it to you to have a healthy lifestyle (exercise, eat right, not smoke, and
see a doctors regularly)?
6.) What can doctors/nurses do to help you make changes to your lifestyle?
Topic: Experience with Survivorship
1.) Is there anything you wish the doctor would have told you?
2.) Was there anything that surprised you or that you didn’t expect?
3.) Is there anything else you would like to tell me about your health after cancer treatment
that we did not talk about?

Appendix C: Integration of Quantitative and Qualitative Findings
Relationships between Domains and Data Sources
Domain
HINTS Survey Item(s)
Receipt of Care
Plan

“Did you ever receive a summary document from
your doctor or other health care professional that
listed all of the treatment you received for your
cancer?”

Patient-Centered
Communication

How often did the doctors, nurses, or other health
care professional you saw during the past 12
months do each of the following: (1) Give you a
chance to ask all the health related questions you
had? (Fostering Healing Relationships) (2) Give
the attention you needed to your feelings and
emotions? (Responding to emotions) (3) Involve
you in decisions about your health care as much
as you wanted? (Making decisions) (4) Make
sure you understood the things you needed to do
to take care of your health? (Enabling selfmanagement) (5) Explain things in a way you
could understand? (Exchanging Information) (6)
Help you deal with feelings of uncertainty about
your health or healthcare? (Managing
uncertainty).

Health SelfEfficacy

“Overall, how confident are you about your
ability to take good care of your health?”

Aerobic physical
activity

Fruit/Vegetable
consumption

“In a typical week, how many days do you do
any physical activity or exercise of at least
moderate intensity, such as brisk walking,
bicycling at a regular pace, and swimming at a
regular pace?”;
“On the days that you do any physical activity or
exercise of at least moderate intensity, how long
do you typically do these activities?”
“About how many cups of fruit (including 100%
pure fruit juice) do you eat or drink each day?
“About how many cups of vegetables (including
100% pure vegetable juice) do you eat or drink
each day?

Semi-Structure Interview Question
1.) Did you get any papers before you
left?
a. What did it cover? Was it helpful?
Was there anything missing? How have
you used the information since the visit?
1.) Did your doctor/nurse make you feel
comfortable asking questions? (Fostering
Healing Relationships)
2.) Did you doctor make sure you
understood the things you needed to do
to take care of your health after cancer
treatment? (Exchanging Information)
3.) Did your doctor give you all the
information or resources you need to
help you make decisions? (Making
Decisions)
4.) Did your doctor/nurse talk with you
about how to cope with any fears, stress,
and other feelings you may have after
cancer treatment? (Responding to
Emotions)
5.) Did your doctor/nurse make sure that
you understood the next steps in your
health after cancer treatment? (SelfManagement)
6.) Cancer patients often face
uncertainties about life after cancer
treatment. For example, patients may not
know what will happen, if the cancer
will come back, or who to go to for help.
How well did your doctor/nurse help you
deal with the uncertainties about your
cancer? (Managing Uncertainty)
1.) Do you feel good about your ability
to take good care of your health after
cancer treatment? Why?
2.) What would make you feel better
about taking care of your health?

1.) How many minutes of exercise do
you get per week?

1.) How many servings of fruit and
vegetables do you eat per day?

Relationships between Domains and Data Sources
Tobacco use

“Have you smoked at least 100 cigarettes in your
entire life?”

1.) Do you smoke?

Physical Health

“In general, would you say your health is…”

1.) When it comes to your health, how
do you know that you are doing well
after cancer?

Appendix D: Additional Analyses for Paper 1
Sample characteristics and SEM in those diagnosed with breast and colorectal cancer compared
to breast and colorectal cancer survivors who completed active treatment.
HINTS Sample 1: Includes respondents diagnosed with breast and/or colorectal cancer. Defines
survivors as those diagnosed with cancer.
HINTS Sample 2: Includes respondents diagnosed with breast and/or colorectal cancer who have
received and completed treatment for cancer.
Participant Characteristics
HINTS Sample 1
HINTS Sample 2
(N = 273)
(N = 212)
N (Weighted %a)
Cancer Type
Breast
Colorectal
Time Since Completing Tx
< 1 year
1-5 years
5-10 years
> 10 years
Still receiving Treatment
Missing
Gender
Male
Female
Missing
Age Group
18-49
50-64
65-74
75+
Missing
Education
Less than High School
High School Graduate
Some College
College Graduate or More
Missing
Race
NH White
NH Black
Hispanic
NH Other
Missing
Income
Less than $20,000
$20,000 to < $35,000
$35,000 to < $50,000
$50,000 to < $75,000
$75,000 or More
Missing

200 (70.9)
71 (29.1)

158 (73.8)
54 (26.2)

19 (8.3)
57 (19.1)
59 (21.7)
77 (33.7)
30 (17.3)
31

19 (10.0)
57 (23.1)
59 (26.2)
77 (40.7)
-

32 (15.4)
230 (84.6)
9

24 (8.7)
184 (91.3)
4

12 (4.5)
92 (40.9)
77 (25.1)
80 (29.4)
10

8 (3.1)
70 (37.9)
69 (27.2)
60 (31.8)
5

33 (16.2)
73 (28.1)
74 (27.0)
84 (28.7)
7

25 (14.8)
57 (27.6)
61 (28.7)
66 (28.8)
3

155 (74.9)
40 (14.3)
24 (6.7)
15 (4.2)
37

132 (82.1)
32 (2.8)
15 (1.1)
11 (1.4)
22

65 (24.0)
50 (19.6)
31 (10.2)
35 (16.9)
52 (29.3)
38

54 (25.1)
37 (17.4)
24 (8.7)
28 (19.3)
43 (29.5)
26

Participant Characteristics
HINTS Sample 1
HINTS Sample 2
(N = 273)
(N = 212)
N (Weighted %a)
Health Insurance
Yes
253 (94.6)
199 (95.0)
No
13 (5.4)
10 (5.0)
Missing
5
3
a
Sample and replicate weights were applied to account for the complex survey
design and to ensure estimates are representative of the US population. Some
values may not equal 100.
Description of HINTS Variables
HINTS Sample 1
HINTS Sample 2
(N = 273)
(N = 212)
Mean (SD) or N (Weighted %a )
Receipt of SCP
Yes
90 (37.7)
86 (38.1)
No
131 (62.3)
123 (61.9)
Patient-Centered Communicationb
20.8 (0.3)
20.7 (0.3)
Health Self-Efficacyc
3.7 (0.1)
3.7 (0.1)
Aerobic physical activity
0 min/week
117 (45.1)
84 (39.6)
0-149 min/week
94 (32.1)
76 (32.7)
>150 mins/week
59 (22.8)
51 (27.7)
Fruit/Vegetable Intake
< 3-5 servings/day
112 (32.5)
84 (33.1)
> 3-5 servings/day
161 (67.5)
128 (66.9)
Tobacco Use
Never
164 (60.0)
128 (62.0)
Former or Current
104 (40.0)
82 (38.0)
BMI
29.0 (0.7)
28.7 (0.9)
Number of Chronic Conditions
1.6 (0.1)
1.7 (0.1)
Self-reported Physical Healthc
2.9 (0.1)
3.1 (0.1)
Abbreviations: SD, Standard Deviation
a
Sample and replicate weights were applied to account for the complex survey design and to ensure
estimates are representative of the US population.
b
Overall score of the sum of six items on a 4-point likert scale with higher scores indicate higher values
on construct (max score 24)
c 5-point likert scale with higher scores indicating higher values on construct
Standardized Factor Loadings for Latent Structure for Lifestyle Behaviors
and Physical Health
HINTS Sample 1
HINTS Sample 2
(N = 273)
(N = 212)
Parameters
17
17
Fit Indices
Chi-Square p-value
0.29
0.23
RMSEA
0.03
.04
CFI
0.98
0.96
WRMR
0.49
0.49
Standardized Item Loadings
b (SE)
Health Behaviors
PA
0.98 (0.18)***
0.96 (0.18)***
Smoke
0.19 (0.14)
0.12 (0.16)

FV
Physical Health
Self-reported health
BMI
# of Chronic Conditions
PH with HB
* P-value < 0.05
*** p-value < 0.01

0.41 (0.14)***

0.45 (0.13)***

0.55 (0.08)***
-0.53 (0.11)***
-0.48 (0.08)***
0.69 (0.14)***

0.59 (0.10)***
-0.47 (0.12)***
-0.65 (0.08)***
0.63 (0.15)***

Standardized Total, Direct, and Indirect Effects
HINTS Sample 1
(N = 273)
b (SE)
p-value
Patient-Centered Communication to Physical Health
Total effect
0.33 (0.12)
0.01
Indirect effect
0.12 (0.05)
0.02
Direct effect
0.22 (0.12)
0.08
Patient-Centered Communication to Health Behaviors
Total effect
0.27 (0.12)
0.02
Indirect effect
0.09 (0.06)
0.16
Direct effect
0.19 (0.11)
0.12

HINTS Sample 2
(N = 212)
b (SE)
p-value
0.34 (0.11)
0.11 (0.06)
0.23 (0.12)

<0.01
0.06
0.05

0.27 (0.12)
0.09 (0.07)
0.18 (0.13)

0.02
0.21
0.14

HINTS Sample 1 Model

Appendix E: Description of Themes and Domains
Domain

Definition

Patient-Provider Communication
Information
Description of the
Exchange
information exchange with
the provider during the last
visit and any
communication since the
last visit.

Supporting Quote
I guess just a general little checkup and just letting me
know what was coming next as far as just follow up
stuff... and it was just you did great, everything turned
out- looked like it’s working good, your skin looks
good um- it was just a real positive appointment, if
I’m remembering correctly, and she- just very friendly

(65 year old, NH white, stage I breast cancer
survivor).

Written

Verbal

Any mention of receiving
written information from a
healthcare provider and the
types of topics covered in
the written information.

Any description of what
the oncology provider
discussed with the patient
and the types of topics
covered during the
discussion.

Ensuring patient
understanding

Description of how the
provider makes sure that
the patient understands the
information received

Eliciting questions or
concerns

Any mention of the patient
asking questions or feeling
comfortable asking health
related questions
Any mention of how the
patient and provider make
decisions.

Making Decisions

They [oncology providers] provided me with the
information. Not just tell me, they also gave me the uh
the printout of what I needed to do and how I needed
to take care of myself and what to expect (49 year old,
NH black, stage III colorectal cancer survivor).
[The papers] you know, stuff like if I have any
problems, you know, like stuff like if I’m hurting or
sore and stuff like that and it showed me how to take
care of the wound that I had on my stomach and stuff
like that, and it was just stuff like that, and if I have
any problems, you know, I call the nurse if I feel pain
and all this stuff- they gave me some pain medicine so
I’m good with that (53 year old, NH black, stage II
colorectal cancer survivor).
Well, I mean the doctor I have is very matter of fact,
you know what I mean? I mean she tells me that it’s
not completely gone, but that we can- we’re just going
to have to monitor it and see if it’s getting any better,
and I mean she’s explained to me that nothing is
100% and so therefore as long as we can continue to
monitor the cancer that I have and try to prevent it
from spreading or getting any bigger that that’s pretty
much all we can do right now (54 year old, NH white,
stage I breast cancer survivor).
They just told me that, you know, like exercise, you
know, do the right thing, you know, take care of your
body, don’t stress out and stuff like that- watch your
blood pressure and stuff like that and just take care of
yourself. Don’t eat the type of food that’s going to
bring this back (53 year old, NH black, stage II
colorectal cancer survivor).
Well, like I’ll talk to the oncologist and then she’ll
say- [XXX], do you understand?- and I’ll be like- Yes.
And she’ll say- Okay, well explain to me what I told
you (54 year old, NH white, stage I breast cancer
survivor).
Uh she [provider] actually go over it with me uh and
then ask me if I have questions about what she just
talked about and if I have a question, I’ll ask her (59
year old, NH black, Stage III breast cancer survivor).
Um, I can’t think of any instance where I did not feel
that they had given me everything, yeah. I felt- I would
say yes they gave me everything I needed (65 year old,
NH white, stage I breast cancer survivor).

Responsive/Available

When the patient mentions
how the provider makes
themselves available to the
patient to address their
healthcare needs

Responding to
Patient Needs

Description of how the
provider shows interest and
sensitivity to patients
problem/emotions

Gaps in
Communication

Any mention of what
oncologists/nurse/providers
could have told the patient
following active treatment.

...she called me back when she did it, and she actually
faxed it all for me and called me and let me know that
I could come and pick up the original if I needed it. So
she’s pretty good about following up with anything I
need (59 year old, NH black, Stage III breast cancer
survivor).
I was scared and I told my doctor and they said- We
at [hospital], we’re always going to take good care of
our patients and that’s what I like to hear. If a doctor
to tell me that, I’m not scared no more (53 year old,
NH black, stage II colorectal cancer survivor).
Um, maybe it would be easier for us to take a piece of
paper in- like I said, I have a lot of conditions and just
to have that listed somewhere on there, because
sometimes when I go to the ER, I don’t feel like
answering a bunch of questions. If they already know,
then they can proceed and go ahead…So like even
though that way I can tell them what’s wrong right
that minute and this is all the problems that I have
going on because most of the time I end up in ICU
anyway (56 year old, NH white, stage II breast cancer
survivor).

Oncology Care Teams Responsibilities
Setting up
appointments

Scheduling
labs/radiology

Referring patients to
other healthcare
providers

Providing access to
outside resources

Adherence Behaviors

Any mention of the
provider scheduling future
follow-up appointments
specific to cancer
Any mention of the
provider scheduling or
ordering labs/radiology/or
prescribing medication
Any mention of the
oncology provider
referring patients to other
healthcare providers
(primary care, specialty,
etc.)
Any mentions of the
oncology provider
referring or giving
information to patients
about support groups and
resources outside the
healthcare system (exercise
classes, nutrition courses,
financial assistance, etc.)

I mean she’s given me all the tools that I need to be
able to take care of myself as best I can. I mean like I
said, she’s got all these appointments scheduled for
me, all this lab work scheduled for me ... (54 year old,
NH white, stage I breast cancer survivor).

He sets up the appointments I ask for and stuff, and he
gets to the bottom of the problem. If he can’t, he sets
you up with somebody else that can. So I talk to him
pretty well (56 year old, NH white, stage II breast
cancer survivor).
They also gave information about exercise programs
that are out there uh one at the Baylor Rehab, one at
the YMCA’s- it was neat to have a group there
because one or two people spoke up about other
exercise facilities and programs that are available for
cancer survivors that [xxx]…(65 year old, NH white,
stage I breast cancer survivor).

Yeah, I had an appointment already set up with
another mammo- I can’t remember if it’s six months
or a year, but just to do the breast exam, and if I find
something different then let them know and they’ll set
up an appointment (56 year old, NH white, stage II
breast cancer survivor).

Cancer Surveillance

Any mention of going to
follow up appointments
and getting labs/radiology
as directed by the oncology
care team.

Well, I need to continue with all of the followups. I
need to have my CT scans done on a regular basis to
make sure that none of it has gotten any larger and
that it’s not in other places, things like that (54 year
old, NH white, stage I breast cancer survivor).
I gotta take my pills for five years. Uh-huh, take those
pills and I can’t run out of them. I always get them,
and I take one every- one a day (70 year old, NH
black, breast cancer survivor).

Engaging in healthy
lifestyle behaviors

Any acknowledgement of
the need or current
engagement in diet,
exercise, and smoking
cessation.

Barriers to managing
health

Any mention of barriers to
getting support or
managing health

Survivorship Experience

I’m going to listen to them and when they tell me- and
like they tell me, Ms. [XXX], you know, they try to
help me get off of the cigarettes. I’m going to get off of
them cigarettes. They talk to me, you know, and [in
case it might] you know you gotta do cause sometimes
[it] come back… (70 year old, NH black, breast
cancer survivor).
Um, not really uh because I’m not able to afford
health insurance so that would be my only thing about
me being able to follow up with my health, you know,
because of the financial part of it but, you know, I
have to worry about that when it happens. (59 year
old, NH black, Stage III breast cancer survivor).
I mean they’ve always told me from the time I had my
daughter that I needed to lose weight, and I just never
did it so and I mean I’ve known that I needed to cut
down on the sugar and the sweets and the cokes and
things like that and there again, I didn’t do it. It was
my choice not to do it so I can’t say that there’s any
experience that I’ve had that I wasn’t really prepared
for (54 year old, NH white, stage I breast cancer
survivor).

Physical Health

Mental Health

Any mention of symptoms
experiences since
completing active
treatment.

Any mention of mental
health symptoms since
completing active
treatment.

Um, gratefully the fatigue is lessening, and I’m able to
get on with doing things that I haven’t been able to
commit to doing because I didn’t know how long I
would be fatigued. From the beginning treatment, I
can’t think of the name of that particular drug in that
chemo, a side effect of it has been neuropathy in my
fingers and toes. So that’s still lingering, but I don’t
know if I’m just getting used to it or if it’s lessening,
you know, from time to time I don’t even think about it
and then like right now it’s tingling as I’m- oh, yeah it
has that tingling effect in my fingers kind of thing (65
year old, NH white, stage I breast cancer survivor).
Well, I got a lot of other problems other than that so I
still stay tired a lot…Yeah from my- and my bones
hurt and stuff like that, but it’s not from the cancer.
It’s from everything else that’s wrong with me (56
year old, NH white, stage II breast cancer survivor).
Mentally, uh not very good...Not very good, and I
think it’s mostly because of not knowing, you know,
what the mastectomy would actually look like (59 year
old, NH black, Stage III breast cancer survivor).
Well I’m doing well. I never was concerned when I
had the cancer. It never did bother me. I never did
stress out over it (70 year old, NH black, breast
cancer survivor).

Pre-Cancer Function

Unexpected
Experiences

Any mention of being able
to do the things they used
to be able to do before
cancer treatment.

Anything that the patient
did not expect to
experience following
cancer treatment.

So I mean I all in all, I do okay. I’m able to do my own
laundry. I can shower myself…Well, I don’t have as
much pain as I used to have. I’m not quite so tired all
the time like I used to be. I definitely have a little bit
more energy than I used to have, and the lumps where
the masses were have- the swelling in that area I
guess is what I’m trying to say, has gone down so like
I said, I’m better able to move my arm and my
shoulder now than what I used to be able to be (54
year old, NH white, stage I breast cancer survivor).
I can do things that I wasn’t able to do after the
surgery. Four months after the surgery, I can do it
now so I think I’m doing pretty good (59 year old, NH
black, Stage III breast cancer survivor).
Oh I guess I could- there’s a lot. I mean, you know,
you hear about going through the chemo and all the
side effects and I guess I didn’t expect it to be as bad
as it was with the side effects for the chemo, but I
mean I knew about them, I just had never personally
experienced them so I wasn’t ready for those side
effects like the hair loss, the nausea, the vomiting. I
wasn’t expecting it to be as bad as it actually was (54
year old, NH white, stage I breast cancer survivor).

Motivation to stay
healthy

Social Support

Discussion around
anything that motivates the
respondent to get better
after cancer treatment.

Discussion about how
family and friends provide
support following cancer
treatment.

Well, it’s pretty important because I’m trying to stay
healthy. I mean I’ve got a granddaughter that’s only
nine so yeah it’s important to me to stay healthy. I
mean she’s the only grandchild and her greatgrandma [xxx] she’s 82. Her great, great aunt she
lives with is 74. I mean I gotta stay healthy to be
around for her. So I got a motivation. Motivated to
stay healthy enough to where I’ll be around for a
while (56 year old, NH white, stage II breast cancer
survivor).
Well, they really motivate me, you know, like I wasyou know, I would say to myself I’m a little down and
out or something like that. I used to talk to myself, by
myself, and say why me and all this stuff. Why do I
have to have this, but then when I seen the doctors
and stuff, they talk to me about it and I was like- they
was telling me don’t be scared, don’t be nervous and
then when they- I just focused on what they was
saying to me, and it made me feel better just like
telling me that it’s going to be okay, you know, we can
take it out of you and stuff like that (53 year old, NH
black, stage II colorectal cancer survivor).
Yeah, I can do more stuff and things like that. I mean I
try to keep the house around here. They both work,
we’re roommates so there’s- like last night. I couldn't
cook. I was nauseous, you know, hey- y’all are going
to have to cook. Yeah, so that’s just how it works
around here when I get sick, I start slowing down, and
they’re like- I think you need to go get checked out (56
year old, NH white, stage II breast cancer survivor).
My sister-in-law went through this pretty much the
same type thing I’ve gone through a year earlier and
so she was able to kinda give me a heads up on some
things or if I’d ask her- did you have this or that and
she said- oh yeah, that goes away. So it was very
helpful. (65 year old, NH white, stage I breast cancer
survivor).
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